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Abstract 
We hypothesized that repetitive umbilical cord occlusions (UCOs) leading to severe acidemia 
will stimulate a placental and fetal inflammatory response associated with brain injury, which 
will be exacerbated by chronic hypoxemia and low-grade infection. Chronically instrumented 
fetal sheep served as controls or underwent repetitive UCOs for up to 4 hours or until fetal 
arterial pH was <7.00. Normoxic-UCO and hypoxic-UCO fetuses had arterial O2 saturation 
pre-UCOs of >55% and <55%, respectively, while lipopolysaccharide (LPS)-UCO fetuses 
received LPS intra-amniotically (2mg/h) starting 1 hour pre-UCOs. Fetal plasma and amniotic 
fluid were sampled for cytokines and after 48 hours of recovery placental and brain tissue were 
processed for measurement of inflammation and brain injury. Repetitive UCOs resulted in 
severe fetal acidemia with pH approaching 7.00 for all 3 UCO groups. All UCO groups had 
increased neutrophils in the placental zona-intima. LPS-UCO animals had elevated IL-6 in 
fetal plasma at 1-hour recovery, which was highly correlated with nadir pH attained (r =.97). 
Repetitive UCOs with severe acidemia can induce a placental inflammatory response, more so 
with low-grade inflammation and likely contributing to cytokine release into umbilical 
circulation. Despite up to 4 hours of repetitive UCOs and severe acidemia in most of these 
animals, there was no significant effect on measures of brain inflammation or injury, except in 
the LPS-UCO animals where TUNEL+ cells were increased in the hippocampus. As such, the 
near-term ovine fetal brain shows remarkable tolerance for these cord occlusion insults and 
likely involving protective metabolic mechanisms, despite the severe acidemia noted.    
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Fetal hypoxia; placental inflammation; LPS; microglia; brain necrosis; brain apoptosis; 
neutrophils; macrophages; interleukin 6; interleukin 1β   
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Chapter 1 
1.1 Inflammation and Fetal Brain Injury 
1.1.1 Intrauterine Infection and Fetal Brain Injury 
Exposure of the fetus to inflammation in utero is a known risk factor for the development of 
neurobehavioral disorders later in life, including cerebral palsy, autism and schizophrenia.1-5 
Although inflammation is a natural aspect of pregnancy and labour, various adverse events 
such as intrauterine infection, perinatal hypoxia, or labour complications can disrupt the 
balance of pro- and anti-inflammatory cytokines resulting in adverse neonatal outcomes. 
Between 25% and 40% of preterm births6, and between 8.8% and 23.5% of term births7, are 
complicated by intrauterine inflammation.  Chorioamnionitis is the inflammation of the fetal 
membranes resulting from ascending bacterial infection of the uterus, and is a confirmed risk 
factor for the development of cerebral palsy.5 Yoon et al found that among 123 preterm 
children, those with elevated amniotic IL-6 or IL-8 concentrations at the time of birth were 
significantly more likely to have developed cerebral palsy by the age of 3.8  Likewise, Shalak 
et al found that infants born to mothers with chorioamnionitis had elevated levels of IL-6 and 
IL-8 in umbilical cord blood, and those infants with the highest cytokine levels were more 
likely to develop hypoxic-ischemic encephalopathy (HIE).9  Additionally, Viscardi et al found 
that in preterm infants, elevated cerebrospinal fluid IL-6 and TNFα was associated with cranial 
ultrasound abnormalities.10  These clinical and epidemiological studies suggest that the release 
of pro-inflammatory cytokines due to infection during pregnancy is a significant mediator of 
neonatal brain injury, and could have long term implications on brain development in the 
infant. 
Animal based studies with induced perinatal infection/inflammation further support the 
contributory role of cytokines and inflammatory cells in perinatal brain injury.  
Lipopolysaccharide (LPS) is a membrane component of gram-negative bacteria that bind toll-
like receptors expressed on a variety of immune and non-immune cell types to stimulate an 
acute inflammatory response, and is a commonly used tool in the study of 
infection/inflammation in relation to neonatal brain injury.  Kallapur et al11 were the first to 
demonstrate in preterm fetal sheep that intraamniotic exposure to LPS (~20 mg) resulted in 
increased expression of IL-6, IL-8, and IL-1β in the chorion and amnion, as seen in 
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chorioamnionitis. Nitsos et al12 exposed preterm fetal sheep to LPS (1.1 mg/d for 28 days by 
amniotic infusion), and found that amniotic fluid IL-6 and IL-8 were both elevated at delivery. 
Additionally, most LPS exposed fetuses had focal areas of white matter injury, as well as a 
greater degree of activated microglia compared to control animals. In a similar study where 
preterm sheep were exposed chronically to intravenous LPS over 5 days, exposed fetuses had 
elevated plasma TNFα, increased number of activated microglia in the subcortical white 
matter, and also exhibited signs of white matter injury.13 This study demonstrated that 
inflammation in the absence of other major physiologic disturbances such as hypoxemia, 
hypercapnia, or acidemia is able to cause brain injury.  In rabbits, intrauterine infection  with 
e. coli administration at 80% gestation resulted in notable apoptotic cell death in fetal 
periventricular white matter, and in some cases cystic white matter lesions comparable to 
periventricular leukomalacia (PVL) seen in humans.14  More recently, maternal infection by E. 
coli has been associated with increased neuronal apoptosis in the hippocampus as well as 
subsequent impairment of spatial learning and memory abilities in rat pups15.  These studies 
together corroborate the notion derived from human studies that infection and subsequent 
elevation of pro-inflammatory cytokines plays a significant contributory role in the 
development of neonatal brain injury. 
1.1.2 Intrauterine Hypoxia and Brain Injury 
Intrauterine growth restriction (IUGR) is another known risk factor for neonatal brain injury 
which may lead to the development of long term neurological sequelae including cerebral 
palsy, autism, and schizophrenia,16-18 and is associated with chronic hypoxia during the latter 
part of pregnancy.19,20  Both clinical and experimental studies have linked IUGR with increased 
production of pro-inflammatory cytokines. McElrath et al 21 found that infants with IUGR, had 
increased risk of elevated pro-inflammatory cytokines including IL-1β, IL-6, TNF-α, and IL-8 
14 days after birth. In a study looking at IUGR in guinea pigs, gene expression for 22/113 
cytokines and/or receptors were upregulated in chronically hypoxic fetuses; among them were 
TNFα, IL-1β, and IL-1r1 receptor.22  These chronically hypoxic fetuses also exhibited 
decreased neuronal density and increased rates of apoptosis in the hippocampus.22 These 
studies indicate that chronic hypoxia in the days or weeks prior to birth may be a significant 
source of inflammation, and thereby has the potential to sensitize the neonatal brain to injury.  
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While either infection or hypoxia alone is sufficient to induce neonatal brain injury, there is 
evidence that infection can also predispose a fetus to hypoxic-ischemic brain injury. 
Epidemiological evidence indicates that the risk for developing cerebral palsy is greater in 
fetuses exposed to both infection and hypoxia compared to those exposed to hypoxia alone.23   
Similarly, exposure of 7 day old rat pups to LPS,  administered to either the peritoneal cavity 
or the cerebrospinal fluid, sensitized their brains to a subsequent hypoxic/ischemic insult that 
would otherwise be inert.24,25  Other studies have shown that rat pups exposed to LPS prior to 
a hypoxic insult had increased number of apoptotic cells26 and blood-brain-barrier damage.27  
Taken together, these studies indicate intrauterine infection can sensitize the fetal brain to 
hypoxic injury. A possible mechanism by which infection could promote hypoxic injury was 
suggested by Garnier et al28, whereby changes in cardiovascular function due to bacterial 
infection would result in altered cerebral blood flow. Indeed, intrauterine infection can alter 
fetal cardiovascular function resulting in reduced cerebral blood flow and subsequent hypoxic 
injury.29  Under normal circumstances, a fetus is able to alter brain metabolism and redistribute 
blood flow in order to maintain its  essential energy requirements and to avoid brain injury in 
response to a hypoxic insult.30 However increased systemic pro-inflammatory cytokines due 
to infection might impair the fetus’ ability to adapt to a hypoxic insult, thereby increasing the 
likelihood of injury.  
1.1.3 Labour Events and Inflammation 
Inflammation is a normal and essential aspect in the induction, maintenance, and termination 
of healthy pregnancies.31,32  Normal term labour is accompanied by increases in pro-
inflammatory cytokines IL-6, and IL-833, indicating that these cytokines play a role in the 
normal progression of labour. However adverse events near term, such as compression of the 
umbilical cord during labour leading to severe hypoxic-acidemia, can result in excessive 
production of pro-inflammatory cytokines, and in turn increase risk for neonatal morbidity.34,35 
Chiesa et al34 studied term neonates and found that IL-6 was elevated in the umbilical cord 
blood of neonates that had perinatal asphyxia and subsequently developed HIE (22(1.9-9743) 
pg/ml; P < 0.0001) compared to those without perinatal asphyxia. In a similar study, Silveira 
et al35 found that IL-6 and TNFα were elevated in the cerebrospinal fluid of neonates with HIE 
compared to normal controls, at 157.5 (66.8-288) pg/ml (p < 0.00001) and 14.7 (13.8-15.3) 
pg.ml (p < .00001), respectively. These studies reinforced the notion that pro-inflammatory 
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cytokines have a role in the pathogenesis of hypoxic brain injury.  Additionally, placental 
hypoperfusion resulting from compression of the umbilical cord during labour has been shown 
to stimulate secretion of IL-6 and TNFα by the placenta36, suggesting that labour itself is a 
possible trigger for the production of pro-inflammatory cytokines.   
 
1.2 Pro-inflammatory Cytokines and the Fetal Inflammatory 
Response 
1.2.1 Pro-inflammatory Cytokines and Pregnancy 
Cytokines are a class of small soluble peptides or glycoproteins produced by a variety of cell 
types including leukocytes and endothelial cells, among others.  They function primarily as a 
means of intracellular communication, with a plethora of autocrine, paracrine, and endocrine 
effects, and thus play an integral role in the regulation of the innate immune response.43  
Cytokines can be classified based on the effect they have on their effector cells; some cytokines 
are pro-inflammatory such as IL-1β, IL-8 and TNFα, some are anti-inflammatory such as IL-
10, and some can be pleiotropic like IL-6, having both pro- and anti-inflammatory effects 
depending on the target-cell type, cytokine concentration, and/or other environmental 
conditions.43  In vivo, cytokines are always acting among a milieu of other cytokines and 
messenger molecules, and so the end result of an inflammatory cascade usually depends upon 
a complex interplay between pro- and anti-inflammatory signals. 
Inflammation is a normal aspect of a healthy term pregnancy, with pro-inflammatory cytokines 
having essential functions at all stages including implantation, maintenance, and parturition. 
Implantation involves the adhesion of a blastocyst to the endometrium, followed by secretion 
of proteinases thus allowing for proliferation and invasion of trophoblasts. IL-1β promotes 
secretion of proteinases by trophoblasts37,38, while IL-6 increases their bioactivity.39  In 
addition, both IL-1β and IL-6 have been shown to promote proliferation of first trimester 
trophoblasts40.  Insufficient invasiveness of trophoblast cells leading to placental ischemia later 
in pregnancy is strongly associated with preeclampsia41, thus emphasizing the importance of 
these cytokines in the establishment of pregnancy.  After implantation, pro-inflammatory 
cytokines are also involved in the production and secretion of a variety of hormones throughout 
the course of pregnancy.   Production of human chorionic gonadotropin (hCG), is promoted by 
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IL-1β, IL-6 and TNFα among others; secretion of both corticotropin releasing hormone (CRH) 
and adrenocorticotropic hormone (ACTH) by the placenta is stimulated by IL-1β; and finally, 
estradiol production by placental cells is increased after exposure to IL-1β or TNFα.32 
Additionally, pro-inflammatory cytokines are involved in processes of parturition, including 
cervical ripening, rupture of the fetal membranes, and contraction of the uterus during labour.32  
Involvement of pro-inflammatory cytokines in these processes not only highlights their 
functional importance throughout pregnancy, but also illustrates the many points of 
vulnerability should an abnormal inflammatory response occur.   
1.2.2 The Fetal Inflammatory Response Syndrome 
The fetal inflammatory response syndrome (FIRS) was first defined by Gomez et al.42  in 
fetuses with premature labour or preterm premature rupture of membranes (PPROM) by a  cord 
blood IL-6 concentration of 11 pg/ml or greater, and was determined to be an independent risk 
factor for severe neonatal morbidity, most notably respiratory distress syndrome and sepsis. 
Presently, the literature has shown that a fetal inflammatory response may be triggered by both 
bacterial infection or by signals released from injured tissue, is not limited to fetuses with 
premature labour or PPROM, and involves many cytokines in addition to IL-6.  Accordingly, 
FIRS is now more broadly defined as the systemic activation of the fetal innate immune 
system.43  Gotsch et al43 suggested that the FIRS is a means for a fetus to escape a hostile 
intrauterine environment, whereby signals for infection/injury trigger the release of pro-
inflammatory cytokines by the fetus and placenta eventually leading to the induction of labour, 
citing the fact that infants who survived the neonatal period were more likely to show signs of 
an inflammatory response than an infant who died in the perinatal period.44   Despite its 
potential survival value, the FIRS has been linked to dysfunction or abnormalities in every 
major organ system, including the fetal brain.43  It is well established that a fetal inflammatory 
response can result from intrauterine infection12,13,24,25,43, IUGR21,22, and acute 
hypoxia/ischemia34,35. Therefore, neonatal morbidity associated with neonatal brain injury is 
likely to result from a culmination of all these factors.   
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1.3 The Placenta and Inflammation 
1.3.1 Neutrophils 
Neutrophils are the most abundant type of white blood cell, and are an integral part of the 
innate immune system.  When stained with hematoxylin and eosin (H&E) neutrophils appear 
light pink with a dark multilobular nucleus and visible granules within its cytoplasm.  Normally 
found in the systemic circulation, neutrophils migrate quickly to sites of injury or infection and 
are usually among the first immune cells to appear.  The extravasation of neutrophils from 
blood vessels is facilitated by the expression of specific cell adhesion molecules on endothelial 
cells in response to stimulants including bacterial LPS or cytokines such as IL-1β and TNFα.45  
Once at the site of inflammation neutrophils can phagocytose foreign microbes, release 
cytoplasmic granules containing a variety of antimicrobial molecules, or form neutrophil 
extracellular traps (NETs) which are networks of extracellular fibers with antimicrobial 
properties. 
The immune response to infection or injury in the placenta, like other tissues, consists firstly 
of a prompt arrival of neutrophils followed later by macrophages, T-cells and dendritic cells.46  
Neutrophils first appear in the subchorionic fibrin within 6-12 hours of the inflammatory 
stimulus, migrating from the maternal blood in the intervillous space.47  Second, neutrophils 
migrate from the maternal decidual vessels to the fetal amnion, chorion, and associated 
connective tissue, thus comprising the condition of histological chorioamnionitis.47  All 
neutrophils within the placenta are maternal in origin, with the exception of those found in the 
chorionic plate vessels, which are of fetal origin.48  Inflammation of the chorionic plate vessels 
and umbilical cord, termed chorionic vasculitis and funisitis, respectively, is indicative of a 
fetal inflammatory response.  This thesis will use neutrophil infiltration into the ovine placenta 
as an indicator of inflammation within the placenta.  
1.3.2 Macrophages 
Macrophages are a type of white blood cell found in tissues under a state of inflammation.  
Their general functions consist of, but are not limited to, phagocytosis of pathogens and cellular 
debris, antigen presentation, as well as modulation of the immune response through secretion 
of cytokines and chemokines.  Macrophages are present in the decidua, as well as in the 
placenta throughout pregnancy and are believed to have a variety of tissue-specific functions 
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including: vascular remodeling of the uterine lining during placentation, immunomodulation 
of the materno-fetal interface, and preparation of the cervix for parturition.49  Additionally, 
macrophages in the placenta and decidua can function as activators of the innate immune 
system in response to bacterial infection through activation of membrane bound pattern 
recognition receptors, for example Toll-like receptors (TLRs)49 or CD16350. 
CD163 is a scavenger receptor of the cysteine-rich superfamily (SRCR) expressed exclusively 
on macrophages and monocytes, including those found in the placenta.  It is best  characterized 
as a membrane receptor involved in the clearance of free hemoglobin in the blood resulting 
from the breakdown of red blood cells, thereby protecting tissue from oxidative damage.51 
Recently CD163 has been shown to bind gram-positive and gram-negative bacteria and trigger 
the production of pro-inflammatory cytokines52,  suggesting that CD163 may also be involved 
in the initiation of an innate immune response to bacterial infection. 
1.3.3 Mast Cells 
It is well established that mast cells play a vital role in reproductive processes, particularly 
during initiation and maintenance of pregnancy where they aid in tissue remodeling, 
angiogenesis, placentation, and spiral artery modifications.53 Additionally, there is evidence 
that excessive mast cell degranulation can lead to preterm labour, as might be seen in women 
with systemic mastocytosis54 or allergy-associated induction of preterm labour.55-57 
Conversely, Menzies et al58 found that mast-cell deficient mice underwent labour at the same 
time as wild-type controls, suggesting that the normal initiation of labour is not dependent on 
mast cell activity. In the context of hypoxia and/or ischemia, researchers have found that mast 
cells are the earliest responders to hypoxia-ischemia in the brain, likely by acutely affecting 
blood brain barrier permeability.59 In near term fetal sheep subjected to repetitive umbilical 
cord occlusion with severe acidemia, mast cells in the choroid plexus were increased two fold 
compared to controls.60  However, the role of mast cells in placental inflammation is not well 
studied. To our knowledge this is the first study looking at mast cells in the ovine placental 
cotyledon.  
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1.4 The Brain and Inflammation 
1.4.1 Microglia as the Primary Immune Cell Within the Brain 
Microglia are the innate immune cell of the central nervous system and their physiologic roles 
include phagocytosis of cellular debris, and induction of neuronal cell death during normal 
development. While in their resting state, microglia take on a ramified appearance. However, 
when exposed to certain stimuli such as inflammation61, infection13, neuronal death62, trauma 
and ischemia63, they can become activated and more numerous.  Activated microglia secrete a 
variety of inflammatory mediators including reactive oxygen species64, nitrous oxide65, pro-
inflammatory cytokines66,67, and quinolinic acid.68  Although these mediators are normally 
beneficial, prolonged activation of microglia can result in elevation of these mediators beyond 
normal physiologic levels, at which point they can become neurotoxic.  Aggregations of 
microglia have been found in the dentate gyrus of neonates exposed to hypoxia-ischemia.69  
Increased microglia activation has also been shown in the white matter of mid-term ovine 
fetuses exposed to either hypoxia-ischemia or systemic endotoxemia,70 as well as in the white 
matter and hippocampus of near-term ovine fetus exposed to hypoxia-ischemia60 or chronic 
systemic endotoxemia.13 Lehnardt et al71 showed that LPS induced oligodendrocyte death is 
dependent on toll-like receptor 4 (TLR4) which are expressed solely on microglia within the 
CNS. Similarly, pharmacological inhibition of microglia proliferation after CNS injury in vivo 
reduced neuronal injury compared to control animals.72   This evidence strongly implicates the 
role of activated microglia in the pathogenesis of brain injury. 
1.4.2 The Role of Mast Cells 
Mast cells are potent effector cells in the innate immune system that function primarily by 
storing and secreting a variety of biological molecules including histamines, prostaglandins, 
and cytokines.59,73  In the brain, there is increasing evidence that mast cell activity in response 
to hypoxia-ischemia can lead to brain injury.  In rat pups subjected to unilateral cerebral 
hypoxia-ischemia via ligation of the right common carotid artery, mast cell numbers were 
significantly increased in the ligated side compared to the non-ischemic side, and areas of high 
mast cell numbers were also those with increased activated microglia and brain injury.74  
Furthermore, inhibition of mast cell degranulation attenuated brain injury due to the hypoxic-
ischemic insult.74  In near term ovine fetuses subjected to repetitive umbilical cord occlusion 
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with severe acidemia, we found a two-fold increase in mast cell numbers in the choroid plexus 
compared to control animals.60 
1.5 Umbilical Cord Occlusions in the Ovine Fetus 
Variable fetal heart rate (FHR) decelerations are the most common non-reassuring FHR pattern 
seen intrapartum, and are caused by compression of the umbilical cord leading to fetal 
hypoxemia.75 If umbilical cord occlusions (UCO) during labour are of sufficient duration and 
severity, fetal acidemia may develop,76 and consequently the infant will be at greater risk of 
long term neurological sequelae.77,78 Itskovitz et al79, using the chronically catheterized ovine 
fetus, elucidated that the fetal heart rate response to UCOs was dependent on the degree of 
blood flow reduction in the umbilical cord, as well as on the UCO duration.  There have been 
many studies using the catheterized near-term ovine fetus to investigate the effects of UCOs 
on brain injury and inflammation, all with varying UCO duration, severity and frequency.  
Intermittent UCOs without cumulative acidemia, consisting of 90-second UCOs every 30 
minutes for 3 to 5 hours, is generally well tolerated by the ovine fetus, with minimal signs of 
necrotic cell injury80, and no signs of apoptotic cell injury.81  However, fetuses exposed to these 
intermittent UCOs did show widespread changes in brain structural proteins, including 
vimentin, glial fibrillary acidic protein, and  nestin.82  These studies indicate that while the fetal 
brain can tolerate limited hypoxic insults without suffering overt damage, more subtle changes 
can occur which may impact long term brain development. Prout et al60 subjected near-term 
ovine fetuses to a series of repetitive UCOs consisting of 1-minute occlusion every 5 minutes 
for 1 hour, 1-minute occlusion every 3 minutes for 1 hour, followed by 1-minute occlusions 
every 2 minutes until the fetus attained an arterial pH of < 7.0.  This study found that repetitive 
UCOs with severe acidemia resulted in a ~2-fold increase in IL-1β in the fetal circulation, a ~2 
fold increase in microglia numbers in the white matter and hippocampus, and a ~2-fold increase 
in mast cells within the thalamus and choroid plexus .60  This study demonstrated that repetitive 
UCOs with severe fetal acidemia can result in a fetal inflammatory response, both systemically 
and locally within the brain, which might then contribute to subsequent brain injury. 
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1.6 Rationale, Hypothesis, and Research Objectives 
1.6.1 Rationale 
Variable fetal heart rate (FHR) decelerations are the most common non-reassuring FHR pattern 
observed intrapartum, and are indicative of acute fetal hypoxia due to repetitive umbilical cord 
occlusion (UCO) with uterine contractions during labour.75  Repetitive UCOs of sufficient 
duration and frequency will result in worsening fetal acidemia, which can become severe 
defined as fetal arterial pH < 7.0.83  These infants are at risk of developing hypoxic-ischemic 
encephalopathy (HIE) and long term neurological sequelae, including cerebral palsy.78 
However, the majority of these infants will be without long term complications, indicating that 
other factors may be involved in the development of brain injury in addition to the degree of 
hypoxic-acidemia at birth.77 
Elevated pro-inflammatory cytokines are well associated with increased risk for fetal-neonatal 
brain injury.12,13, 24  The release of pro-inflammatory cytokines into the fetal circulation can be 
secondary to a variety of conditions, including infection both antenatal and intrapartum43, 
chronic hypoxemia with intra-uterine growth restriction during the antenatal period22, and 
acute hypoxia occurring during labour and leading to hypoxic-acidemia at birth.34,35, 43, 84 Since 
these insults can each on their own initiate an inflammatory response, there is the potential for 
them to act concomitantly contributing to brain injury.  As such, this thesis will study the 
additive effects of low-grade bacterial infection as might be seen in patients with histologic 
chorioamnionitis at the time of delivery, as well as chronic hypoxemia as seen with fetal growth 
restriction, on the fetal-placental inflammatory response to repetitive UCOs. 
The placenta is an important source of pro-inflammatory cytokines that under normal 
physiological conditions play an important role in the initiation, maintenance, and completion 
of healthy pregnancies.31  Cells in the placenta shown to produce pro-inflammatory cytokines 
include trophoblasts, stromal cells, vascular endothelial cells and macrophages.32 However 
studies have shown that placental hypoxia or hypoperfusion can also trigger the production of 
pro-inflammatory cytokines by the placenta with potential for release into the fetal 
circulation32,36, supporting the contention that reduced uterine or umbilical blood flow during 
labour with contractions can cause an increase in circulating pro-inflammatory cytokines in the 
fetus, thereby predisposing to hypoxic brain injury. This thesis will examine fetal plasma 
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cytokines as marker for systemic inflammation and amniotic fluid cytokines as marker of 
placental inflammation in the near term ovine fetus in response to repetitive UCOs. 
In the placenta neutrophils are recruited from the maternal blood through expression of cell 
adhesion molecules on endothelial cells in response to injury or infection.85 The presence of 
neutrophils in the amnion and chorion is considered to be the hallmark of placental 
inflammation with histological chorioamnionitis.47   Macrophages can be found within the 
placenta throughout pregnancy where they have a variety of functions.49  Notably, 
macrophages within the placenta can function as activators of the innate immune system in 
response to bacterial infection through activation of their membrane bound receptors such as 
toll-like receptors (TLRs) or CD163.49,50  Upon activation, macrophages can secrete reactive 
oxygen species, nitric oxide, and pro-inflammatory cytokines.49 Little is known of mast cells 
in the placenta and their role in the placental inflammatory response.  However they are widely 
recognized as key cellular components of inflammatory processes through the secretion of 
biologic mediators, including cytokines, histamine, and prostaglandins, among others.  This 
thesis will examine neutrophils, macrophages, and mast cells within the placental cotyledons 
of the near term ovine fetus as markers of a placental inflammatory response to repetitive 
UCOs.  
Within the fetal brain, microglia are the primary immune cells, which can become activated in 
response to injury or infection. Upon activation they can secrete various inflammatory 
mediators including reactive oxygen species64, nitrous oxide65, and pro-inflammatory 
cytokines65,66 , all of which can be neurotoxic. Mast cells are another type of immune cell that 
can be found sparsely within the fetal brain, and have been implicated in the pathogenesis of 
inflammatory brain injury.59,60,73  This thesis will examine microglia and mast cells within the 
brain of the near term ovine fetus as markers of a local inflammatory response to repetitive 
UCOs. Apoptosis and necrosis will additionally be assessed as markers for brain injury.   
1.6.2 Hypotheses 
1) Repetitive UCOs leading to severe fetal acidemia as might be seen clinically during labour 
with non-reassuring FHR decelerations, will initiate a placental inflammatory response with 
an increase in neutrophils, macrophages and mast cells in the placenta causing an increase in 
pro-inflammatory cytokines in the fetal circulation and amniotic fluid. Pre-existing chronic 
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hypoxia or low-grade inflammation, as might be seen with fetal growth restriction or histologic 
chorioamnionitis, will exacerbate the fetal-placental inflammatory response to repetitive 
UCOs. 
2) Repetitive UCOs leading to severe fetal acidemia and systemic inflammation, will initiate a 
brain inflammatory response with increased activated microglia and mast cells, and thereby an 
increase in necrotic and apoptotic cell death in the fetal brain.  Pre-existing chronic hypoxia or 
low-grade inflammation, as might be seen with fetal growth restriction or histologic 
chorioamnionitis, will exacerbate the fetal brain inflammatory and injury response to repetitive 
UCOs. 
1.6.3 Objectives 
1) To determine the change in neutrophil, macrophage, and mast cell numbers in the placental 
cotyledons, and in pro-inflammatory cytokines in the fetal circulation and amniotic fluid in 
response to repetitive UCOs with severe acidemia in the near-term ovine fetus, with and 
without pre-existing chronic hypoxia or low grade inflammation. 
2) To determine the change in microglia and mast cell numbers, and in necrotic and apoptotic 
cell death in the brain in response to repetitive UCOs with severe acidemia in the near-term 
ovine fetus, with and without pre-existing chronic hypoxia or low grade inflammation. 
  
 13 
1.7 References 
1.  Brown AS. Epidemiologic studies of exposure to prenatal infection and risk of 
schizophrenia and autism. Dev Neurobiol. 2012;72(10):1272–1276. 
2.  Canetta SE, Brown AS. Prenatal infection, maternal immune activations, and risk for 
schizophrenia. Transl Neurosci. 2012;3(4):320–327. 
3.  Himmelmann K, Ahlin K, Jacobsson B, Cans C, Thorsen P. Risk factors for cerebral 
palsy in children born at term. Acta Obstet Gynecol Scand. 2011;90(10):1070–1081. 
4.  Nelson KB, Grether JK. Potentially asphyxiating conditions and spastic cerebral palsy 
in infants of normal birth weight. Am J Obstet Gynecol. 1998;179(2):507–513. 
5.  Wu YW, Colford JM. Chorioamnionitis as a risk factor for cerebral palsy: A meta-
analysis. JAMA. 2000;284(11):1417–1424. 
6.  Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of 
preterm birth. Lancet. 2008;371(9606):75–84. 
7.  Becroft DMO, Thompson JMD, Mitchell EA. Placental Chorioamnionitis at Term: 
Epidemiology and Follow-Up in Childhood. Pediatr Dev Pathol. 2010;13(4):282–
290. 
8.  Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, Han TR. Fetal exposure to 
an intra-amniotic inflammation and the development of cerebral palsy at the age of 
three years. Am J Obstet Gynecol. 2000;182(3):675–681. 
9.  Shalak LF, Laptook AR, Jafri HS, Ramilo O, Perlman JM. Clinical chorioamnionitis, 
elevated cytokines, and brain injury in term infants. Pediatrics. 2002;110(4):673–680. 
10.  Viscardi RM, Muhumuza CK, Rodriguez A, Fairchild KD, Sun C-CJ, Gross GW, 
Campbell AB, Wilson PD, Hester L, Hasday JD. Inflammatory markers in 
intrauterine and fetal blood and cerebrospinal fluid compartments are associated with 
adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res. 
2004;55(6):1009–1017. 
11.  Kallapur SG, Willet KE, Jobe AH, Ikegami M, Bachurski CJ. Intra-amniotic 
endotoxin: chorioamnionitis precedes lung maturation in preterm lambs. Am J Physiol 
Lung Cell Mol Physiol. 2001;280(3):L527–L536. 
12.  Nitsos I, Rees SM, Duncan J, Kramer BW, Harding R, Newnham JP, Moss TJ. 
Chronic exposure to intra-amniotic lipopolysaccharide affects the ovine fetal brain. J 
Soc Gynecol Investig. 2006;13(4):1–9. 
13.  Duncan J, Cock M, Suzuki K, Scheerlinck JP, Harding R, Rees S. Chronic Endotoxin 
Exposure Causes Brain Injury in the Ovine Fetus in the Absence of Hypoxemia. J Soc 
Gynecol Investig. 2006;13(2):87–96. 
 14 
14.  Debillon T, Gras-Leguen C, Vérielle V, Winer N, Caillon J, Rozé JC, Gressens P. 
Intrauterine infection induces programmed cell death in rabbit periventricular white 
matter. Pediatr Res. 2000;47(6):736–742. 
15.  Jiang PF, Zhu T, Gao JD, Gao F, Mao SS, Zhao WT, Gu WZ, Yu HM. The effect of 
maternal infection on cognitive development and hippocampus neuronal apoptosis, 
proliferation and differentiation in the neonatal rats. Neuroscience. 2013;246:422–
434. 
16.  Nelson KB, Grether JK, Dambrosia JM, Walsh E, Kohler S, Satyanarayana G, Nelson 
PG, Dickens BF, Phillips TM. Neonatal cytokines and cerebral palsy in very preterm 
infants. Pediatr Res. 2003;53(4):600–607. 
17.  Cannon M, Jones PB. Obstetric complications and schizophrenia: historical and meta-
analytic review. Am J Psychiatry. 2002 Jul;159(7):1080-92. 
18.  Dalman C, Thomas HV, David AS, Gentz J, Lewis G, Allebeck P. Signs of asphyxia 
at birth and risk of schizophrenia. Population-based case-control study. Br J 
Psychiatry. 2001;179:403–408. 
19. Soothill PW, Nicolaides KH, Campbell S. Prenatal asphyxia, hyperlacticaemia, 
hypoglycaemia, and erythroblastosis in growth retarded fetuses. Br Med J (Clin Res 
Ed). 1987;294(6579):1051–1053. 
20.  Cox WL, Daffos F, Forestier F, Descombey D, Aufrant C, Auger MC, Gaschard JC. 
Physiology and management of intrauterine growth retardation: a biologic approach 
with fetal blood sampling. Am J Obstet Gynecol. 1988;159(1):36–41. 
21.  McElrath T, Allred E, Van Marter L, Fichorova R, Leviton A, ELGAN Study 
Investigators. Perinatal systemic inflammatory responses of growth-restricted preterm 
newborns. Acta Paediatr. 2013 Oct.;102(10):e439-42. 
22.  Guo R, Hou W, Dong Y, Yu Z, Stites J, Weiner CP. Brain Injury Caused by Chronic 
Fetal Hypoxemia Is Mediated by Inflammatory Cascade Activation. Reprod Sci. 
2010;17(6):540–548. 
23.  Ugwumadu A. Infection and fetal neurologic injury. Curr. Opin. Obstet. Gynecol. 
2006;18(2):106–111. 
24.  Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, 
Hagberg H. Bacterial endotoxin sensitizes the immature brain to hypoxic--ischaemic 
injury. Eur J Neurosci. 2001;13(6):1101–1106. 
25.  Coumans ABC, Middelanis J, Garnier Y, Vaihinger H-M, Leib SL, Duering Von MU, 
Hasaart THM, Jensen A, Berger R. Intracisternal Application of Endotoxin Enhances 
the Susceptibility to Subsequent Hypoxic-Ischemic Brain Damage in Neonatal Rats. 
Pediatr Res. 2003;53(5):770–775. 
 15 
26. Wang L-W, Chang Y-C, Lin C-Y, Hong J-S, Huang C-C. Low-dose 
lipopolysaccharide selectively sensitizes hypoxic ischemia-induced white matter 
injury in the immature brain. Pediatr Res. 2010;68(1):41–47. 
27.  Yang D, Sun Y-Y, Nemkul N, Baumann JM, Shereen A, Dunn RS, Wills-Karp M, 
Lawrence DA, Lindquist DM, Kuan C-Y. Plasminogen activator inhibitor-1 mitigates 
brain injury in a rat model of infection-sensitized neonatal hypoxia-ischemia. Cereb. 
Cortex. 2013;23(5):1218–1229. 
28.  Garnier Y, Coumans ABC, Jensen A, Hasaart THM, Berger R. Infection-related 
perinatal brain injury: the pathogenic role of impaired fetal cardiovascular control. J 
Soc Gynecol Investig. 2003;10(8):450–459. 
29.  Fukuda S, Yokoi K, Kitajima K, Tsunoda Y, Hayashi N, Shimizu S, Yoshida T, 
Hamajima N, Watanabe I, Goto H. Influence of premature rupture of membrane on 
the cerebral blood flow in low-birth-weight infant after the delivery. Brain Dev. 
2010;32(8):631–635. 
30.  Richardson BS. The fetal brain: metabolic and circulatory responses to asphyxia. Clin 
Invest Med. 1993;16(2):103–114. 
31.  Romero R, Gotsch F, Pineles B, Kusanovic JP. Inflammation in pregnancy: its roles 
in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev. 
2007;65:S194–S202. 
32.  Bowen JM, Chamley L, Keelan JA, Mitchell MD. Cytokines of the placenta and 
extra-placental membranes: roles and regulation during human pregnancy and 
parturition. Placenta. 2002;23(4):257–273. 
33.  Chan CJ, Summers KL, Chan NG, Hardy DB, Richardson BS. Cytokines in umbilical 
cord blood and the impact of labor events in low-risk term pregnancies. Early Hum 
Dev. 2013;89(12):1005–1010. 
34.  Chiesa C, Pellegrini G, Panero A, De Luca T, Assumma M, Signore F, Pacifico L. 
Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal 
asphyxia. Eur. J. Clin. Invest. 2003;33(4):352–358. 
35. Silveira RC, Procianoy RS. Interleukin-6 and tumor necrosis factor-α levels in plasma 
and cerebrospinal fluid of term newborn infants with hypoxic–ischemic 
encephalopathy. J Pediatr. 2003;143(5):625–629. 
36.  Pierce B. Hypoperfusion causes increased production of interleukin 6 and tumor 
necrosis factor α in the isolated, dually perfused placental cotyledon. Am J Obstet 
Gynecol. 2000;183(4):863–867. 
37.  Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, Sadovsky Y, Quigley JP, 
French DL, Fisher SJ. Interleukin-1 beta regulates human cytotrophoblast 
metalloproteinase activity and invasion in vitro. J. Biol. Chem. 1994;269(25):17125–
17131. 
 16 
38.  Shimonovitz S, Hurwitz A, Barak V, Dushnik M, Adashi EY, Anteby E, Yagel S. 
Cytokine-mediated regulation of type IV collagenase expression and production in 
human trophoblast cells. J. Clin. Endocrinol. Metab. 1996;81(8):3091–3096. 
39.  Meisser A, Cameo P, Islami D, Campana A, Bischof P. Effects of interleukin-6 (IL-6) 
on cytotrophoblastic cells. Mol. Hum. Reprod. 1999;5(11):1055–1058. 
40.  Bowen JM, Chamley L, Mitchell MD, Keelan JA. Cytokines of the Placenta and 
Extra-placental Membranes: Biosynthesis, Secretion and Roles in Establishment of 
Pregnancy in Women. Placenta. 2002;23(4):239–256. 
41.  Raghupathy R. Cytokines as Key Players in the Pathophysiology of Preeclampsia. 
Med Princ Pract. 2013.;22 Suppl 1:8-19 
42.  Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal 
inflammatory response syndrome. Am J Obstet Gynecol. 1998;179(1):194–202. 
43.  Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, Espinoza J, 
Hassan SS. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 
2007;50(3):652–683. 
44.  Madan E, Meyer MP, Amortequi A. Chorioamnionitis: a study of organisms isolated 
in perinatal autopsies. Ann. Clin. Lab. Sci. 1988;18(1):39–45. 
45.  Borregaard N. Neutrophils, from marrow to microbes. Immunity. 2010;33(5):657–
670. 
46.  Menon R, Taylor RN, Fortunato SJ. Chorioamnionitis--a complex pathophysiologic 
syndrome. Placenta. 2010;31(2):113–120. 
47.  Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal 
Neonatal Med. 2006; (11): 296-301. 
48.  Lee SD, Kim MR, Hwang PG, Shim S-S, Yoon BH, Kim CJ. Chorionic plate vessels 
as an origin of amniotic fluid neutrophils. Pathol. Int. 2004;54(7):516–522. 
49.  Nagamatsu T, Schust DJ. Review: The Immunomodulatory Roles of Macrophages at 
the Maternal--Fetal Interface. Reprod Sci. 2010;17(3):209–218. 
50.  Kacerovsky M, Cobo T, Hornychova H, Andrys C, Ryska A, Musilova I, Kriz JT, 
Kostal M, Jacobsson B. Scavenger receptor for hemoglobin in preterm prelabor 
rupture of membranes pregnancies complicated by histological chorioamnionitis. J 
Matern Fetal Neonatal Med. 2012;25(11):2291–2297. 
51.  Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor 
CD163. Immunobiology. 2005;210(2-4):153–160. 
52.  Fabriek BO, van Bruggen R, Deng DM, Ligtenberg AJM, Nazmi K, Schornagel K, 
Vloet RPM, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor 
 17 
CD163 functions as an innate immune sensor for bacteria. Blood. 2009;113(4):887–
892. 
53.  Woidacki K, Jensen F, Zenclussen AC. Mast cells as novel mediators of reproductive 
processes. Front Immunol. 2013;4:29. 
54.  Metcalfe DD, Akin C. Mastocytosis: molecular mechanisms and clinical disease 
heterogeneity. Leuk. Res. 2001;25(7):577–582. 
55.  Romero R, Kusanovic JP, Muñoz H, Gomez R, Lamont RF, Yeo L. Allergy-induced 
preterm labor after the ingestion of shellfish. J Matern Fetal Neonatal Med. 
2010;23(4):351–359. 
56.  Habek D, Cerkez-Habek J, Jalsovec D. Anaphylactic shock in response to wasp sting 
in pregnancy. Zentralbl Gynakol. 2000;122(7):393–394. 
57.  Bytautiene E, Romero R, Vedernikov YP. Induction of premature labor and delivery 
by allergic reaction and prevention by histamine H 1 receptor antagonist. Am J Obstet 
Gynecol. 2004 Oct;191(4):1356-61. 
58.  Menzies FM, Higgins CA, Shepherd MC, Nibbs RJB, Nelson SM. Mast cells reside 
in myometrium and cervix, but are dispensable in mice for successful pregnancy and 
labor. Immunol. Cell Biol. 2012;90(3):321–329. 
59.  Lindsberg PJ, Strbian D, Karjalainen-Lindsberg M-L. Mast cells as early responders 
in the regulation of acute blood&ndash;brain barrier changes after cerebral ischemia 
and hemorrhage. J Cereb Blood Flow Metab. 2010;30(4):689–702. 
60.  Prout AP, Frasch MG, Veldhuizen RAW, Hammond R, Ross MG, Richardson BS. 
Systemic and cerebral inflammatory response to umbilical cord occlusions with 
worsening acidosis in the ovine fetus. Am J Obstet Gynecol. 2010;202(1):82.e1–9. 
61.  Kuno R, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. Autocrine 
activation of microglia by tumor necrosis factor-alpha. J. Neuroimmunol. 2005;162(1-
2):89–96. 
62.  Dheen ST, Kaur C, Ling E-A. Microglial activation and its implications in the brain 
diseases. Curr. Med. Chem. 2007;14(11):1189–1197. 
63.  Lai AY, Todd KG. Microglia in cerebral ischemia: molecular actions and interactions. 
Can. J. Physiol. Pharmacol. 2006;84(1):49–59. 
64.  Yoshida T, Tanaka M, Sotomatsu A, Hirai S. Activated microglia cause superoxide-
mediated release of iron from ferritin. Neuroscience Letters. 1995;190(1):21–24. 
65.  Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate 
neuronal cell injury via a nitric oxide mechanism. J Immunol. 1992 Oct.;149(8)2736-
2741. 
 18 
66.  Giulian D, Baker TJ, Shih LC, Lachman LB. Interleukin 1 of the central nervous 
system is produced by ameboid microglia. J. Exp. Med. 1986;164(2):594–604. 
67.  Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumor necrosis 
factor-alpha by microglia and astrocytes in culture. Brain Research. 
1989;491(2):394–397. 
68.  Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP. Human microglia 
convert l-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 1996;320 
(Pt2):595–597. 
69.  Bigio MRD, Beckery LE. Microglial aggregation in the dentate gyrus: a marker of 
mild hypoxic-ischaemic brain insult in human infants. Neuropathology and Applied 
Neurobiology. 1994;20(2):144–151. 
70.  Mallard C, Welin A-K, Peebles D, Hagberg H, Kjellmer I. White matter injury 
following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem. Res. 
2003;28(2):215–223. 
71.  Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, 
Volpe JJ, Vartanian T. The toll-like receptor TLR4 is necessary for 
lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 
2002;22(7):2478–2486. 
72.  Giulian D, Robertson C. Inhibition of mononuclear phagocytes reduces ischemic 
injury in the spinal cord. Ann Neurol. 1990;27(1):33–42. 
73.  Skaper SD, Giusti P, Facci L. Microglia and mast cells: two tracks on the road to 
neuroinflammation. The FASEB Journal. 2012;26(8):3103–3117. 
74.  Jin Y, Silverman A-J, Vannucci SJ. Mast Cell Stabilization Limits Hypoxic-Ischemic 
Brain Damage in the Immature Rat. Dev Neurosci. 2007;29(4-5):373–384. 
75.  American College of Obstetricians and Gynecologists. Fetal heart rate patterns: 
monitoring, interpretation, and management. Technical bulletin. 1995;207. 
76.  Ball RH, Parer JT. The physiologic mechanisms of variable decelerations. Am J 
Obstet Gynecol. 1992;166(6 Pt 1):1683–8– discussion 1688–9. 
77.  Winkler CL, Hauth JC, Tucker JM, Owen J, Brumfield CG. Neonatal complications 
at term as related to the degree of umbilical artery acidemia. Am J Obstet Gynecol. 
1991;164(2):637–641. 
78.  Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE. A systematic review of 
the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. 
Am J Obstet Gynecol. 2008;199(6):587–595. 
 19 
79.  Itskovitz J, LaGamma EF, Rudolph AM. Heart rate and blood pressure responses to 
umbilical cord compression in fetal lambs with special reference to the mechanism of 
variable deceleration. Am J Obstet Gynecol. 1983;147(4):451–457. 
80.  Rocha E, Hammond R, Richardson B. Necrotic cell injury in the preterm and near-
term ovine fetal brain after intermittent umbilical cord occlusion. Am J Obstet 
Gynecol. 2004;191(2):488–496. 
81.  Falkowski A, Hammond R, Han V, Richardson BS. Apoptosis in the preterm and near 
term ovine fetal brain and the effect of intermittent umbilical cord occlusion. Brain 
Res. Dev. Brain Res. 2002;136(2):165–173. 
82.  Rocha E, Totten S, Hammond R, Han V, Richardson B. Structural proteins during 
brain development in the preterm and near-term ovine fetus and the effect of 
intermittent umbilical cord occlusion. Am J Obstet Gynecol. 2004;191(2):497–506.  
83. Goldaber KG, Gilstrap LC, Leveno KJ, Dax JS, McIntire DD. Pathologic fetal 
acidemia. Obstet Gynecol. 1991 Dec.;78(6):1103–1107. 
84. Hagberg H, Gilland E, Bona E, Hanson LA, Hahin-Zoric M, Blennow M,  Holst M, 
McRae A, and  Söde O. Enhanced expression of interleukin (IL)-1 and IL-6 
messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr 
Res. 1996;40(4): 603-609.  
85. Borregaard N. Neutrophils, from marrow to microbes. Immunity. 2010 Nov. 
24;33(5):657–670.    
  
  
 20 
Chapter 2 
Repetitive Umbilical Cord Occlusions and Fetal Placental 
Inflammation 
2.1 Introduction 
Variable fetal heart rate (FHR) decelerations due to compression of the umbilical cord with 
resultant fetal hypoxemia are the most common non-reassuring FHR pattern observed 
intrapartum.1  Repetitive umbilical cord occlusions (UCOs) during labour of sufficient duration 
and frequency result in worsening fetal acidemia which if prolonged can become severe, 
defined as arterial pH < 7.0.2  Affected infants have an increased risk of developing hypoxic-
ischemic encephalopathy (HIE) and long term neurological sequelae, including cerebral palsy.3  
However, most infants with severe acidemia at birth will be without noted complications, 
suggesting that an infant’s susceptibility to hypoxic-asphyxial injury is multifactorial.4  
Epidemiological and clinical evidence indicates that an increase in pro-inflammatory cytokines 
during infectious processes, both antenatal and postnatal, contributes to the risk for perinatal 
brain injury.5  Subsequent animal-based studies with induced perinatal infection/inflammation 
further support the contributory role of cytokines and inflammatory cells in perinatal brain 
injury5-7, and also indicate a synergistic interaction between inflammation and hypoxia in the 
pathogenesis of brain injury.5,8,9  Similarly, both clinical and experimental evidence suggest 
that the pathogenesis of newborn HIE, in the absence of infection, is mediated by an increase 
in pro-inflammatory cytokines,5,10-12 suggesting hypoxia/asphyxia alone can trigger an 
inflammatory response.  Furthermore pro-inflammatory cytokines have also been implicated 
in the development of brain injury due to chronic intrauterine hypoxia leading to fetal growth 
restriction.13  In short, fetal inflammation can be secondary to a variety of conditions, including 
intrauterine infection, acute asphyxia intrapartum, and chronic hypoxia during the antenatal 
period, all of which have the potential to act concomitantly contributing to perinatal brain 
injury.   
The placenta is a major source of pro-inflammatory cytokines, which under normal conditions 
play a pivotal role in the initiation, maintenance and completion of healthy pregnancies.14 
However, placental hypoxia and/or hypoperfusion can trigger the release of cytokines by the 
placenta,15,16 supporting the contention that reduced uterine or umbilical blood flow due to 
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contractions during labour can cause an increase in circulating inflammatory cytokines in the 
fetus and thus predispose to hypoxic brain injury.   We therefore hypothesized that repetitive 
UCOs leading to severe fetal acidemia will stimulate a placental inflammatory response, along 
with a systemic inflammatory response within the fetus.  Macrophages, neutrophils, and mast 
cells were counted as measures of inflammation in the placental cotyledons at 48 hours of 
recovery, while fetal plasma interleukin (IL) 6 was assessed throughout the experiment as a 
measure of systemic inflammation in response to the repetitive UCOs with worsening 
acidemia. Amniotic fluid IL-6 and IL-1β were additionally assessed at select time points as 
further measures of placental and/or membrane inflammation, since any increase in these 
cytokines is likely attributable to placental/membrane production and release into the amniotic 
cavity.16  We also sought to examine the additional impact on these inflammatory responses of 
lower oxygenation and low-grade bacterial infection as might be seen clinically during labour 
with fetal growth restriction and placental chorioamnionitis.17-20 
 
2.2 Materials and Methods 
2.2.1 Surgical Preparation 
Thirty mixed breed ewes were surgically instrumented at 124-128 days gestation (term = 147 
days) (Figure 2.1).  Anesthesia, surgical procedures, and postoperative (postop) care of the 
animals have been previously described.21  General anesthesia was induced using 1 g of sodium 
pentothal (Abbott Laboratories Ltd., Montreal, Quebec, Canada) given intravenously, followed 
by 1% to 2% isoflurane in O2 for maintenance.  A polyvinyl catheter was placed in the maternal 
femoral vein for administering fluids and antibiotics and for blood sampling.  A midline 
incision was made in the lower abdominal wall to expose the uterus, which was palpated to 
determine fetal number and position.  Fetuses were partially exteriorized through an incision 
in the uterine wall.  Polyvinyl catheters were placed in the left and right brachiocephalic arteries 
for blood sampling and pressure recordings, and the right brachiocephalic vein for 
administering antibiotics.  Stainless-steel electrodes were placed biparietally on the dura to 
monitor electrocortical (ECoG) activity, as well as on the fetal chest to monitor 
electrocardiographic (ECG) activity.  In experimental animals, an inflatable silicone occluder 
cuff (OC14; In Vivo Metric, Healdsburg, California) was placed around the proximal portion  
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Figure 2.1.  Thirty near term ovine fetuses were chronically instrumented at 126 days gestation 
(term = 147 days), as shown above.  Animals were allowed to recover for 4 days prior to 
experimental study. 
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of the umbilical cord and secured to the abdominal skin.  The fetus was then returned to the 
uterus, a polyvinyl catheter was placed in the amniotic cavity for amniotic fluid sampling and 
pressure recordings, and the uterine and abdominal incisions were closed.  Antibiotics were 
administered to the mother (5 cm3 Tivetrin), fetus (1 cm3 Penicillin), and amniotic cavity (1 
cm3 Penicillin) at the end of surgery.  Animals were allowed to recover for four days, during 
which daily maternal and fetal blood samples were taken for blood gases and pH to monitor 
maternal and fetal health.  On postop day 2, a fetal arterial plasma sample (3 mL) was also 
taken for later cytokine analysis.  Catheters were flushed daily with saline in order to maintain 
patency. 
2.2.2 Experimental Procedure 
Animals were divided retrospectively into 4 groups based on postsurgical, sustained baseline 
blood oxygen status. Fetal baseline oxygen status was determined by averaging the arterial O2 
saturation of blood samples taken on each of the 4 postop recovery days, as well as at baseline 
on the day of the UCO experimental study.  Fetuses with average baseline arterial O2 saturation 
of < 55% comprised a low oxygen or hypoxic-UCO group (n = 5), since this level of 
oxygenation has been used to denote decreased oxygenation/spontaneous hypoxemia in the 
near term ovine fetus.22,23  The remaining fetuses with average baseline arterial O2 saturation 
≥ 55% were divided into a normoxic-UCO group (n = 9), LPS-UCO group (n = 6), and control 
group (n = 10). The LPS (E. Coli 055:B5, Sigma Aldrich, Oakville, Ontario, Canada), a 
bacterial endotoxin found on the outer membrane of gram-negative bacteria, was administered 
via hourly intra-amniotic injections of 2 mg/h beginning 1 hour prior to the first UCO to 
simulate a low-grade bacterial infection in LPS-UCO animals.24,25 The control group consisted 
of normoxic fetuses that underwent surgical preparation but were not subjected to UCOs. These 
animals were used only as tissue controls for histological examination of the placental 
cotyledons. 
Umbilical cord occlusions were induced by inflating occluder cuffs with varying volumes of 
saline.  The severity of occlusion was gauged by observing the magnitude of resultant FHR 
decelerations, with decelerations of 30, 60, and 90 bpm corresponding to umbilical blood  
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Figure 2.2. Schematic diagram of the experimental timeline. Each division represents a 
duration of 1 hour. Arrowheads indicate when animals in the LPS-UCO group received intra-
amniotic injections of LPS. LPS indicates lipopolysaccharide; UCO, umbilical cord 
occlusions.  
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flow reduction of approximately 50%, 75%, and 100%, respectively, as reported by Itskovitz 
et al.26 These targeted occlusions and associated FHR deceleration of 30, 60, and 90 bpm were 
deemed, “mild-partial”, “moderate-partial”, and “severe-complete” UCOs, respectively.  All 
UCOs were 1 minute in duration and occurred every 2.5 minutes. 
On the experimental day, a PowerLab system was used for data acquisition and analysis 
(LabChart 6, Adinstruments, Sydney, Australia) to record fetal arterial blood pressure, 
amniotic pressure, ECoG, ECG, and heart rate.  FHR was triggered and calculated online from 
arterial pressure systolic peaks.  All fetuses were monitored for a 1- to 2-hour baseline control 
period. Experimental fetuses were then subjected to series of repetitive UCOs consisting of 1 
hour of mild partial, 1 hour of moderate partial, and up to 2 hours of severe complete UCOs 
(Figure  2.2).  UCOs were discontinued if fetal arterial pH dropped below 7.00, or after two 
hours of severe complete UCOs.  The ewe and fetus were allowed to recover for 48 hours after 
the end of the UCOs, at which time they were euthanized with a barbiturate overdose (30 mg 
sodium pentobarbital, MTC Pharmaceuticals, Cambridge, Ontario, Canada). 
Fetal arterial blood samples (1 mL) were taken at baseline, at the end of a representative UCO 
of each UCO series, every 20 minutes between UCOs, and after 1, 24, and 48 hours of recovery.  
Blood samples were analyzed for blood gases, pH, glucose, and lactate using an automated 
blood gas analyzer (ABL 725, Radiometer Medical, Copenhagen, Denmark) with temperature 
corrected to 39.0°C.   Additional blood samples (3 mL) were collected at baseline prior to 
UCOs, immediately after the final UCO, and at 1 and 48 hours of recovery.  These samples 
were immediately centrifuged at 3400 rpm for 5 minutes at 4° C, with the supernatant (plasma) 
then transferred to a fresh microfuge tube and frozen at -80° C for later analysis of pro-
inflammatory cytokines.  Amniotic fluid samples (3 mL) were taken at baseline prior to UCOs, 
and after 1 and 48 hours of recovery.  These samples were also centrifuged at 3400 rpm for 5 
minutes at 4° C, with the supernatant then transferred to a fresh microfuge tube and frozen at -
80° C for later analysis of pro-inflammatory cytokines.  At the end of the experimental day, 
fetuses were given a transfusion of maternal blood with volume equal to the total volume of 
blood sampled that day.   
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2.2.3 Tissue Histochemical Analysis 
Placental cotyledons that appeared to be of average size were collected from each fetus at 
necropsy.  Cotyledons were immersed in 4% paraformaldehyde for 24 hours, then in fresh 
phosphate buffered saline (PBS) for three days, followed by 70% ethanol for 7 days, then 
blocked and embedded in paraffin for histological analysis. 
Macrophages within the cotyledon were visualized by immunohistochemical staining with a 
mouse anti-CD163 antibody.27,28 Staining was performed using an avidin/biotin based 
peroxidase method (Vectastain Elite Kit, Vector Laboratories, Burlingame, California). Tissue 
sections were deparaffinized with three 5-minute washes in xylene, then rehydrated in a series 
of ethanol baths (100%, 100%, 90%, 90%, 70%) lasting 2 minutes each.  Tissue sections were 
then rinsed once in pure water for 5 minutes followed by two 5-minute washes in PBS.  For 
antigen retrieval, tissues were boiled in 10 mmol/L citrate buffer for 30 minutes, cooled to 
room temperature for 30 minutes, then rinsed with two 5-minute washes in PBS.  Endogenous 
peroxidase activity was quenched by incubating tissues in 3% H2O2 (Fischer Scientific, 
Ottawa, Ontario, Canada) for 10 minutes followed by two 5-minute washes in PBS.  
Endogenous biotin was blocked by incubating tissues in avidin solution followed by biotin 
solution for 15 minutes each.  To reduce non-specific staining, slides were incubated in 
Background Sniper (Biocare Medical, Concord, California) for 7 minutes at room temperature 
then rinsed in PBS.  Tissue sections were then incubated in mouse anti-CD163 monoclonal 
antibody (1:1000, Acris, San Diego, California) overnight (~20 hours) at 4° C, rinsed with 
three 5-minute washes in PBS, incubated with secondary antibody (1:200, biotinylated anti-
mouse immunoglobulin G [IgG]; Vector Laboratories) for 30 minutes at room temperature, 
and again rinsed with three 5-minute washes in PBS.  Tissue sections were then incubated with 
streptavidin-peroxidase solution (Vector Laboratories) for 45 minutes at room temperature, 
rinsed with three 5-minute washes in PBS, and finally incubated with diaminobenzidine 
(Biocare Medical) for exactly 2 minutes to develop the stain.  Tissue sections were then 
dehydrated in a series of ethanol baths (70%, 70%, 90%, 100%, 100%) followed by 3 5-minute 
washes in xylene and finally cover-slipped using Permount (Fischer Scientific). Negative 
controls were produced using the protocol described above but omitting the primary antibody 
and confirmed absence of staining. 
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Neutrophils within the cotyledons were identified by visual examination of hematoxylin and 
eosin (H&E)-stained slides.  Tissue sections were deparaffinized with three 5-minute washes 
in xylene, then rehydrated in a series of ethanol baths (100%, 100%, 90%, 90%, 70%) lasting 
2 minutes each. Tissue sections were then rinsed once in pure water for 5 minutes before being 
immersed in Haris Modified Haematoxylin stain (Fischer Scientific) for 10 seconds.  Stain was 
differentiated in 1% acid ethanol (2 mL HCl in 198 mL 70% ethanol) for approximately 1 
second, and then flushed under running water for 1 minute. Next, sections were stained with 
eosin (1% eosin Y in 95% ethanol and 0.5% glacial acetic acid, Fischer Scientific) for 
approximately 1 second.  Tissue sections were then dehydrated in a series of ethanol baths 
(70%, 70%, 90%, 100%, 100%) followed by 3 5-minute washes in xylene and finally cover-
slipped using Permount (Fischer Scientific).  
Mast cells within the cotyledon were identified by staining with toluidine blue.  Tissue sections 
were deparaffinized with three 5-minute washes in xylene, then rehydrated in a series of 
ethanol baths (100%, 100%, 90%, 90%, 70%) lasting 2 minutes each. Sections were then rinsed 
once in pure water for 5 minutes followed by two 5-minute washes in PBS, followed by 
immersion in toluidine blue solution (5 mg/mL toluidine blue in 0.1M HCl) for 10 minutes.  
Sections were rinsed under running water for 5 minutes before a quick (10 sec) dip in acid 
alcohol (0.5 mL of glacial acetic acid in 200 mL of 95% ethanol), then dehydrated in a series 
of alcohol baths (70%, 90%, 100%) for 30 seconds each, and finally cover-slipped using 
Permount (Fischer Scientific). 
Cotyledon sections were cut vertically through the centre such that each section contained 
tissue from the entire depth of the cotyledon (Figure 2.3).  For analysis, sections were divided 
into thirds depthwise, with the “fetal zone” consisting of the region most proximal to the fetus, 
the  “zona intima” consisting of the region most proximal to the mother, and the “intermediate 
zone” consisting of the region in between.  Image analysis was performed using a transmitted 
light microscope (Leica DMRB, Leica-Microsystems, Wetzler, Germany).  For each stain, four 
high-power field (HPF) photomicrographs (400x magnification) were taken per cotyledon 
region.  For the macrophage analysis, endocytosis and breakdown of red blood cells by 
chorionic epithelial cells was noted to result in nonspecific binding of the CD163 antibody, 
thus those areas were avoided when imaging.  Macrophages were identified by contiguous, 
dark cytoplasmic staining by DAB and were  
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Figure 2.3. Schematic diagram of a vertical section from an ovine cotyledon. Fetal zone 
images were taken in the chorionic plate above the hemophagous (hem) zone. Intermediate 
zone images were taken in the middle third of the cotyledon, below the hemophagous zone and 
above the zona intima. Zona intima images were taken within the zona intima. Figure from 
Burton et al 1976.29 CD indicates central depression of the cotyledon; ChA, chorioallantois; 
str, stroma; v, chorionic villi.  
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counted manually (Figure 2.4A). Neutrophils were identified from H&E stained sections by 
their round pink cytoplasm and multilobular nucleus (Figure 2.4B), while mast cells were 
identified by their metachromatic cytoplasmic granules, with these inflammatory cells again 
counted manually.  For all analysis, care was taken to avoid counting cells in areas of 
extravasated blood or within blood vessels.  All slides for each staining procedure were 
processed on the same day using the same solutions in order to minimize variation in staining.  
Tissue staining and scoring of cell counts was performed by a single experimenter in a blinded 
fashion to control and experimental groups. 
2.2.4 Enzyme-Linked Immunosorbent Assay Analysis 
Pro-inflammatory cytokines in plasma (IL-6) and amniotic Fluid (IL-6 and IL-1β) were 
analyzed by sheep-specific enzyme-linked immunosorbent assays (ELISA).  First, 96-high 
capacity microtitre well plates were precoated with the capture antibody, using either mouse 
anti-sheep IL-6 (MCA1659; AbD Serotec, Raleigh, North Carolina) or mouse anti-sheep IL-
1β (MCA1658 AbD Serotec) at a concentration of 4 μg/mL overnight at 4° C.  Plates were then 
washed 3 times with PBST (0.05% Tween 20 in PBS, pH 7.4), blocked by incubating with 
assay buffer (1% BSA in PBST) for 1 hour at room temperature, then washed again 3 times 
with PBST.  Protein standards were prepared by serial dilution of either recombinant ovine IL-
6 (Cat No. 968305, Lot No. IL6-911, Protein Express, Cincinnati, Ohio) or recombinant ovine 
IL-1β (Cat No. 968405, Lot No. IL1β-911, Protein Express) in assay buffer.  Amniotic fluid 
and plasma samples were loaded in duplicate and incubated for 2 hours at room temperature.  
If necessary, samples were centrifuged then diluted in assay buffer before being loaded, 
ranging from 1:2 to 1:500.  Unbound proteins were removed by washing 3 times with PBST.  
Plates were then incubated with detection antibody for 30 minutes at room temperature then 
washed 5 times with washing buffer.  Plates were then incubated with detection antibody with 
either rabbit antisheep IL-6 (1:250 dilution, AHP 424; AbD Serotec) or rabbit antisheep IL-1β 
(1:250 dilution, AHP 423; AbD Serotec) for 30 minutes at room temperature then washed 5 
times with washing buffer. Next, 50 µL of rabbit antisheep IgG-HRP (1:5000, Cat no 111-035-
144, Lot no 98733; Jackson ImmunoResearch, West Grove, Pennsylvania) diluted in assay 
buffer were added to each well, plates were incubated for 30 minutes at room temperature, and 
then washed 7 times with washing buffer (with 1 minute incubation between washes).  Finally, 
50 µL of 
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Figure 2.4. Representative photomicrographs (400X) of cotyledon sections from the zona 
intima, (A) stained with CD163 antibody and counterstained with hematoxylin, with 
macrophages exhibiting dark, contiguous cytoplasmic staining and (B) stained with 
hematoxylin and eosin, with neutrophils within the extravascular cotyledon tissue identified 
manually by their pink cytoplasm and multilobular nucleus (arrow). Scale bar = 20 µm.  
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3,30,5,50-tetramethylbenzidine (TMB) substrate solution (BD OptEIA TMB substrate Reagent 
Set, Cat No. 555214; BD Biosciences, Mississauga, Ontario, Canada) was added to each well 
and incubated for 10 to 15 minutes at room temperature. The reaction was stopped by adding 
25 µL of 2 N sulfuric acid to each well. Plates were then read on an ELISA plate reader at 450 
nm with 570 nm wavelength correction (EnVision 2104 Multilabel Reader; Perkin Elmer, 
Waltham, Massachusetts). The sensitivity of the IL-6 ELISA was 16 pg/mL, while the 
sensitivity of the IL-1β ELISA was 1.12 ng/mL. For all assays, the intraassay and interassay 
coefficients of variation were <5% and <10%, respectively. 
2.2.5 Data Analysis 
Differences in arterial blood gases, pH, and metabolites were analyzed using a nonparametric 
1-way analysis of variance test (Kruskal-Wallis) with Dunn posttest for comparisons across 
time points and unpaired T tests for comparisons between groups. Differences in macrophage 
and neutrophil counts among the 4 experimental groups were analyzed using a nonparametric 
1-way analysis of variance test (Kruskal-Wallis) with Dunn posttest for comparing each 
experimental group to the control group. Differences in plasma and amniotic fluid IL-6 and 
IL-1 across the various time points were analyzed using a nonparametric 1-way analysis of 
variance test (Kruskal-Wallis) with Dunn posttest for comparing each time point to baseline 
levels. All statistical analysis was done using Graphpad Prism (Graphpad Software, La Jolla, 
California). All values shown are expressed as means ± standard error of the mean. Statistical 
significance was assumed for P <.05. The ECOG, ECG, and arterial blood pressure findings 
have been reported separately.30-32  
2.3 Results 
2.3.1 Fetal Heart Rate Changes 
Normoxic-UCO animals had average FHR of 159 ± 5 bpm at baseline and showed FHR 
decelerations of 39 ± 8, 59 ± 4, and 99 ± 7 bpm as was intended during the targeted mild partial, 
moderate partial, and severe complete UCOs, respectively. Hypoxic-UCO animals had average 
FHR of 168 ± 5 bpm at baseline and showed FHR decelerations of 29 ± 13, 54 ± 17, and 77 ± 
15 bpm during the mild, moderate, and severe UCOs, respectively, which did not differ from 
that of the normoxic-UCO animals. Finally, LPS-UCO animals had average FHR of 160 ± 3 
bpm at baseline and showed FHR decelerations of 33 ± 9, 51 ± 10, and 91 ± 12 bpm during the 
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mild, moderate, and severe UCOs, respectively, which again did not differ from that of the 
normoxic-UCO animals.  
2.3.2 Fetal Arterial Blood Gas, pH, and Metabolites 
Oxygen saturation and PaO2 at baseline day 1 of study for the normoxic-UCO and LPS-UCO 
groups were within the normal physiologic range, averaging 59% ± 5% and 23.0 ± 0.6 mmHg 
and 57% ± 3% and 23.0 ± 0.6 mmHg, respectively, while that of the hypoxic-UCO group was 
lower, at 40% ± 7% and 16.1 ± 1.8 mmHg (all P < .05). All 3 experimental animal groups had 
normal PaCO2 and pHa values at baseline, which averaged 50.0 ± 1.1, 53.3 ± 1.7, and 51.4 ± 
1.0 mmHg and 7.35 ± 0.01, 7.34 ± 0.01, and 7.35 ± 0.01 for the normoxic-UCO, hypoxic-
UCO, and LPS-UCO groups, respectively. A transient decrease in PaO2 was observed during 
each moderate and severe UCO, at approximately 8 and 13 mmHg, 8 and 12 mmHg, and 8 and 
11 mmHg for the normoxic-UCO, hypoxic-UCO, and LPS-UCO animals, respectively (all P 
< .05; Figure 2.5). The LPS-UCO group also showed a transient decrease in PaO2 of 5 mmHg 
during each mild UCO (P < .05). PaO2 recovered rapidly after the release of the occluder cuff 
and there were no significant changes from respective baseline values as measured at the end 
of each of the UCO series for any of the 3 experimental groups. PaCO2 changed little during 
each mild and moderate UCO but increased during the severe UCOs by approximately 14, 17, 
and 13 mmHg in the normoxic-UCO, hypoxic-UCO, and LPS-UCO groups, respectively (all 
P < .05; Figure 2.5). The increase in PaCO2 values continued to be evident at the end of the 
severe UCO series for all 3 experimental groups but recovered to baseline by 1 hour of 
recovery. Fetal arterial pH likewise changed little during each mild and moderate UCO but 
decreased during the severe UCOs to 7.24 ± 0.01 and 7.10 ± 0.06 in the normoxic-UCO and 
hypoxic-UCO groups, respectively (both P < .05; Figure 2.5). Accordingly, there was a 
cumulative decrease in pHa with the repetitive UCOs, which became significant for the 
normoxic-UCO and hypoxic-UCO groups by the end of the moderate UCO series at 7.28 ± 
0.01 and 7.19 ± 0.05, respectively (both P < .05); and for all 3 experimental groups by the end 
of the severe UCO series at 7.00 ± 0.03, 7.01 ± 0.03, and 7.07 ± 0.06 for the normoxic-UCO, 
hypoxic-UCO, and LPS-UCO groups, respectively (all P < .05; Figure 2.5). Despite up to 2 
hours of severe UCOs, 1 normoxic-UCO animal only reached a nadir pH of 7.19, 1 hypoxic-
UCO animal only  
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Figure 2.5. Graph of fetal arterial PO2, PCO2, and pH (mean ± standard error of the mean 
[SEM]) throughout the UCO and recovery periods. “During” measurements were taken during 
the final 10 seconds of a UCO, while ‘‘end’’ measurements were taken at the end of each UCO 
series between UCOs. *P < .05 compared to respective baseline values. UCO indicates 
umbilical cord occlusion.  
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reached a nadir pH of 7.06, and 1 LPS-UCO animal only reached a nadir pH of 7.14. 
Additionally, in 2 of the LPS-UCO animals, there was difficulty attaining complete inflation 
of the occluder cuff throughout the severe UCO series as indicated by the pressure recording 
from the occluder, with these animals only reaching nadir pHs of 7.25 and 7.20. The average 
time between onset of UCOs and reaching the target nadir pH of 7.00 was shorter in the 
hypoxic-UCO animals at 151 ± 16 minutes compared to the normoxic-UCO animals at 203 ± 
14 minutes (P < .05). Although pHa values showed improvement when measured at 1 hour of 
recovery, they continued to be significantly decreased from respective baseline values for all 
3 experimental groups (all P < .05; Figure 2.5).  
Glucose values at baseline were similar for all 3 experimental groups averaging 1.1 ± 0.1 
mmol/L and showed no significant change until the end of the severe UCO series when 
increased to 2.0 ± 0.2, 2.1 ± 0.2, and 1.7 ± 0.2 mmol/L for the normoxic-UCO, hypoxic-UCO 
and LPS-UCO groups, respectively (all P < .05; Figure 2.6). Lactate values at baseline were 
also similar for the 3 experimental groups averaging 2.0 ± 0.4 mmol/L and again showed no 
significant changes until the end of the severe UCO series when increased to 10.3 ± 1.7, 10.0 
± 2.0, and 10.5 ± 1.6 mmol/L for the normoxic-UCO, hypoxic-UCO, and LPS-UCO groups, 
respectively (all P < .05; Figure 2.6). Although lactate values were somewhat decreased when 
again measured at 1 hour of recovery, they continued to be significantly increased from 
respective baseline values for all 3 experimental groups (all P < .05; Figure 2.6). Of note, one 
of the LPS-UCO animals whose blood gas, pH, and metabolite values appeared to be 
normalizing when measured at 1 hour of recovery, nonetheless had extremely acidotic values 
when measured at 24 hours of recovery, pH 6.86, and lactate 17.0 with this animal then 
immediately sacrificed. Accordingly, while this animal’s measurements up until 1 hour of 
recovery have been included in the LPS-UCO results, they have been excluded thereafter.  
Fetal arterial oxygen saturation, PO2, PCO2, pH, glucose, and lactate values for the control 
group animals, whose tissues were collected as controls for the experimental group animals 
and studied at the same gestational age, were also within the normal physiologic range 
averaging 56% ± 3%, 21.0 ± 0.9 mmHg, 52.3 ± 1.2 mmHg, and 7.35 ± 0.01, respectively.  
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Figure 2.6. Graph of fetal arterial glucose and lactate (mean ± standard error of the mean 
[SEM]) throughout the UCO and recovery periods. “During” measurements were taken during 
the final 10 seconds of a UCO, while “end” measurements were taken at the end of each UCO 
series between UCOs. *P < .05 compared to respective animal group baseline values. UCO 
indicates umbilical cord occlusion.  
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2.3.3 Placental Immunohistochemistry 
In the control group animals, macrophage cell counts were significantly higher within the fetal 
zone at 13.7 ± 2.0 cells/HPF than in the intermediate zone and zona intima at 7.9 ± 1.6 and 7.0 
± 0.9 cells/HPF, respectively (Figure 2.7; both P < .05). However, the 3 experimental UCO 
groups showed similar macrophage cell counts to that of the control group for each of the 
cotyledon zones examined with no significant differences noted (Figure 2.7). In the control 
group animals, neutrophils were found to be absent within the fetal zone, while significantly 
higher in the intermediate zone at 0.7 ± 0.3 cells/HPF and the zona intima at 0.6 ± 0.1 cells/HPF 
(Figure 2.8; both P < .05). In the 3 experimental groups, neutrophils were again found to be 
largely absent within the fetal zone, and cell counts within the intermediate zone were not 
significantly different from control animals (Figure 2.8). However, in the zona intima, 
neutrophil cell counts were approximately 2-fold higher than that of the control group at 1.2 ± 
0.2, 1.4 ± 0.2, and 1.4 ± 0.3 cells/HPF in the normoxic-UCO, hypoxic-UCO, and LPS-UCO 
groups, respectively (Figure 2.8; all P < .05), although these did not differ from one another. 
There was additionally no correlation between baseline oxygen status the day of UCO study 
or averaged postoperatively and zona intima neutrophil cell counts for any of the UCO study 
groups. There were no mast cells seen in any of the cotyledon zones for either the control or 
any of the UCO experimental groups of animals.  
2.3.4 Plasma and Amniotic Fluid Cytokines 
Fetal plasma and amniotic fluid cytokine levels as assessed at select time points throughout the 
study are shown in Table 1. IL-6 was undetectable (concentration <0.016 ng/mL) in fetal 
plasma on postop day 2 for all 3 experimental groups, indicating that any increase in this 
cytokine as a measure of systemic inflammation that might have occurred as a result of the 
surgical procedure was no longer evident. IL-6 was also undetectable in fetal plasma at baseline 
for all 3 experimental groups and continued to be undetectable throughout the UCO and 
recovery periods for the normoxic-UCO and hypoxic-UCO groups. However, plasma IL-6 
values began to increase in the LPS-UCO group animals by the end of the severe UCOs and 
significantly so after 1 hour recovery at 0.22 ± 0.11 ng/mL when compared to respective 
baseline values (P < .05). Of note, this increase in plasma IL-6 values in the LPS-UCO animals 
at 1 hour recovery was highly correlated with the fetal arterial pH nadir at the end of the UCOs 
and thereby the degree of fetal acidemia attained (Spearman r = -.97). Fetal plasma  
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Figure 2.7. Bar graph of CD163-positive macrophages (mean ± standard error of the mean 
[SEM]) within the cotyledon zones expressed as cells/high-power field (HPF). *P < .05 
compared to fetal zone control values. UCO indicates umbilical cord occlusion.  
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Figure 2.8. Bar graph of neutrophils (mean ± standard error of the mean [SEM]) within the 
cotyledon zones expressed as cells/high power field (HPF). *P < .05 compared to fetal zone 
control values; +P < .05 compared to respective control group values. UCO indicates umbilical 
cord occlusion.  
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IL-1β was also analyzed at these same time points in the 3 UCO experimental groups. 
However, results here were extremely variable with values often outside the reference range 
and possibly due to interference with the primary antibody from the assay buffer used in this 
analysis. Accordingly, these results have not been reported.  
Amniotic fluid IL-6 and IL-1β baseline values were similar for all 3 UCO experimental groups, 
averaging 0.08 ± 0.03 and 0.69 ± 0.14 ng/mL for IL-6 and IL-1β, respectively (Table 1). 
Although amniotic fluid IL-6 values in the normoxic-UCO and hypoxic-UCO groups remained 
consistent at 1 and 48 hours of recovery, LPS-UCO animals showed an ~16-fold increase at 
these time points, although this was not significant due to the high degree of variance in the 
response. Likewise, IL-1β values in the normoxic-UCO and hypoxic-UCO groups remained 
consisten at 1 and 48 hours of recovery, whereas the LPS-UCO animals showed an ~10-fold 
(nonsignificant) and 50-fold increase (P < .05) at these respective time points, although again 
with considerable variance in this response.  
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 Postop D2 Baseline End UCO 1 Hour Rec 48 Hours Rec 
Plasma IL-6      
Normoxic-UCO ND ND ND ND ND 
Hypoxic-UCO ND ND ND ND ND 
LPS-UCO ND ND 0.07 ± 0.04 0.22 ± 0.11b 0.03 ± 0.01 
Amniotic Fluid IL-6      
Normoxic-UCO − 0.14 ± 0.06 − 0.10 ± 0.09 0.17 ± 0.08 
Hypoxic-UCO − 0.03 ± 0.01 − 0.02 ± 0.01 0.05 ± 0.02 
LPS-UCO − 0.07 ± 0.03 − 1.13 ± 0.82 1.19 ± 0.97 
Amniotic Fluid IL-1β      
Normoxic-UCO − 0.91 ± 0.45 − 0.90 ± 0.48 0.35 ± 0.14 
Hypoxic-UCO − 0.73 ± 0.35 − 0.62 ± 0.49 0.18 ± 0.05 
LPS-UCO − 0.42 ± 0.19 − 4.41 ± 1.16 22.3 ± 12.7b 
Table 2.1. Plasma and Amniotic Fluid Cytokine Measurements (ng/mL).
a  
 
  
 
Abbreviations: IL, interleukin; LPS, lipopolysaccharide; ND, not detectable; Postop, 
postoperative; rec, recovery; SEM, standard error of the mean; UCO, umbilical cord 
occlusion. 
a
Data are presented as means ± SEMs. 
b
P < .05 compared to respective baseline values; not detectable (concentration <0.016 
ng/mL). 
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2.4 Discussion   
Variable FHR decelerations due to compression of the umbilical cord during contractions are 
the most common nonreassuring FHR pattern seen during human labour, and when frequent 
and/or severe can give rise to concerning fetal acidemia at birth.33 The relationship between 
the cardiovascular response and reductions in umbilical blood flow from compression of the 
umbilical cord has been characterized in the ovine fetus by Itskovitz et al26 who found that the 
magnitude of FHR decelerations was dependent on the degree of UCO, and that a blood flow 
reduction of at least 50% was required to elicit a cardiovascular response. In order to induce 
worsening fetal acidemia with repetitive UCOs, as might occur clinically during human labour, 
we used a UCO paradigm consisting of 60-second UCOs occurring every 2.5 minutes, with 1 
hour of mild-partial cord occlusions, followed by 1 hour of moderate-partial cord occlusions, 
then up to 2 hours of severe-complete cord occlusion. The degree of occluder cuff inflation for 
the mild-partial and moderate-partial occlusions was titrated to affect an FHR response 
associated with a 50% (~25 bpm decelerations) and 75% (~65 bpm decelerations) reduction in 
umbilical cord blood flow, respectively, whereas severe complete occlusions involved 
maximal inflation of the occluder cuff and a complete cessation in umbilical blood flow as 
determined by Itskovitz et al.26  We were able to attain FHR decelerations in the 3 UCO animal 
groups, similar to those seen by Itskovitz as intended, and thereby indicating ~50%, ~75%, and 
100% reductions in umbilical cord blood flow for the mild partial, moderate partial, and severe 
complete UCOs, respectively. However, since umbilical blood flow was not monitored in the 
present study, it is possible that the cardiovascular response to induced UCOs differed among 
the 3 UCO groups and thereby the umbilical blood flow reductions invoked for the mild partial 
and moderate partial UCO series.  
In the normoxic-UCO animals, the mild partial, moderate partial, and severe complete UCOs 
resulted in transitory fetal hypoxemia and hypercapnia of increasing severity the greater the 
reduction in umbilical blood flow. This response was overall similar to that reported by 
Itskovitz et al26 taking into account that their UCOs were of 40-second duration rather than 60 
seconds, and that they directly titrated to the decrease in umbilical blood flow. These repetitive 
UCOs resulted in a cumulative acidosis of a modest degree by the end of the moderate partial 
UCOs, fetal arterial pH to 7.28, and of a marked degree by the end of the severe complete 
UCOs, with pH on average to 7.00 and with 8 of the 9 animals reaching the targeted pH. This 
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worsening acidosis was both respiratory and metabolic in nature with the sustained increase in 
PCO2 and lactate values noted. The hypoxic-UCO animals displayed lower PaO2 values at each 
of the time points studied and not surprisingly took ~50 minutes less on average than the 
normoxic-UCO animals to reach the targeted pH with the repetitive UCOs as studied. Although 
the arterial PO2 and PCO2 changes for the LPS-UCO animals were similar to that of the 
normoxic-UCO animals, it is of note that only 3 of the 6 animals here attained the targeted pH 
of 7.00. This can be attributed in part to the difficulty in 2 of the animals with complete inflation 
of the occluder cuff during the severe UCO series as previously noted but may also relate to 
increased uterine blood flow in these animals with the LPS administration and thereby 
increased oxygen delivery as we have also speculated in the human fetus where oxygenation 
is increased with chorioamnionitis.34  
In all 3 UCO groups, fetal glucose levels increased with repetitive severe complete UCOs to 
1.9 mmol/L on average by the end of the UCOs, likely reflecting an increase in fetal 
glycogenolysis as previously reported in the ovine fetus with sustained hypoxemia and a rise 
in catecholamine levels.35 Fetal lactate levels were likewise similarly increased in all 3 UCO 
groups to 10.3 mmol/L on average by the end of the severe complete UCOs, thereby 
contributing to the marked acidemia at this time as the principal fixed acid leading to metabolic 
acidosis in the fetus.36 This increase in lactate levels presumably reflects the cumulative 
increase in lactate after each cord occlusion and more so for the severe complete UCOs as we 
have previously shown.37  
In the control group animals, no extravascular neutrophils were seen in the chorionic plate or 
fetal zone of the cotyledon while low levels were seen in the intermediate zone and zona intima 
encompassing interdigitating fetal and maternal cotyledon tissues. The presence of neutrophils 
in these areas without apparent inflammatory stimuli is likely due to their close proximity to 
the high volume flow of maternal blood here. In all 3 UCO groups, no differences in neutrophil 
counts were observed in the fetal and intermediate zones compared to that of the control 
animals. However, in the zona intima, neutrophil counts were similarly increased ~2-fold in 
all 3 UCO groups, with no additive effect from underlying hypoxia or LPS. This indicates that 
repetitive UCOs leading to severe fetal acidemia can induce a neutrophil inflammatory 
response within the placenta. Initiating stimuli likely involves placental hypoxia and/or 
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hypoperfusion resulting from the UCOs, which have been shown to increase inflammatory 
cytokines within placental tissues from leukocyte infiltration/activation, decidual stromal cells, 
and placental trophoblast and endothelial cells.15,16 The finding that this UCO-related increase 
in neutrophils was confined to the zona intima of the ovine fetal cotyledon would also suggest 
that this was largely maternal in origin, which is the source of most neutrophils within the 
placenta.38 Although it is somewhat surprising that LPS given intraamniotic did not have an 
apparent effect on neutrophil counts as studied, since infiltration of neutrophils in the fetal 
membranes is a hallmark of chorioamnionitis5. This may be due to the fact that the 
extraplacental fetal membranes were not examined but rather the fetal zone of the ovine 
cotyledon. Although this included the chorionic plate membranes overlying the cotyledon 
depression, the membranes here will be adjacent to fetal tissue and thereby less reflective of a 
maternal inflammatory response than might be expected in the extraplacental membranes that 
are adjacent to the maternal decidua. Although the cotyledon tissues were collected 48 hours 
after the UCOs and LPS administration, and some of the neutrophil inflammatory response 
from these stimuli might now be lessened or no longer evident, this seems unlikely since 
similar LPS administration results in persistence of an inflammatory cell infiltrate in the 
extraplacental membranes for several days.24,25  
Macrophages are normally present in the placenta and contain membrane receptors that 
recognize signaling molecules resulting from injury and/or infectious processes thereby 
triggering inflammatory responses through the release of cytokines including IL-6 and IL-1 
β.39 CD163 is a membrane bound receptor that is highly expressed on tissue macrophages 
including those within the placenta and is not found on other hematopoietic or 
nonhematopoietic tissue cell types.28,39-41 In the control group animals, extravascular CD163-
positive macrophages were seen throughout the cotyledon as studied but were ~2-fold higher 
in the fetal zone when compared to that of the intermediate zone and zona intima. The higher 
number of CD163+ cells within the fetal zone is consistent with the fact that these cells are 
primarily of fetal origin.42 CD163+ macrophage counts were not affected by UCOs and 
associated acidemia nor by underlying hypoxia and LPS. These findings indicate that no 
increased infiltration or proliferation of macrophages was evident as measured at 48 hours of 
recovery but do not rule out increased activation of macrophages already present in the placenta 
 44 
nor of an earlier macrophage inflammatory response within the placenta to these stimuli, 
although this again seems unlikely.41,43  
Mast cells are widely recognized as mediators of inflammatory processes through the secretion 
of a variety of biological molecules including histamine, prostaglandins, and cytokines.44 To 
our knowledge, this is the first study of mast cells in the ovine placental cotyledons, which 
were absent under control conditions and in response to repetitive UCOs and underlying 
hypoxia and LPS exposure, although they can be found in the term human placenta.45 
Accordingly, mast cells may play little if any role in the placental inflammatory response to 
noxious stimuli, which could be protective since the placenta has a high potential for 
encountering triggering stimuli, and mast cell degranulation and histamine release can have a 
variety of effects on the fetus,46 including a trigger for preterm labor.47  
The proinflammatory cytokines IL-1β and IL-6 have been identified as measures of 
fetal/placental inflammation because these cytokines play a prominent regulatory role in the 
inflammatory response and have been shown to increase as part of the fetal/neonatal 
inflammatory response to infection and HIE.5,10-12 Fetal plasma IL-6 was undetectable in all 
animals on postop day 2 indicating that any increase in this cytokine as a result of the surgical 
procedure was no longer evident. This is to be expected given the short half-life of cytokines 
and need for repeated stimuli for continued production.5 Plasma IL-6 continued to be 
undetectable in the normoxic-UCO and hypoxic-UCO animals throughout the UCO and 
recovery periods, which is somewhat surprising since IL-6 has been shown to increase in the 
cord blood of newborn infants with perinatal asphyxia.10,11 Although this may relate to species-
specific differences, it is also likely that additional triggering stimuli are contributory in the 
human newborns including the impact of labor and in some instances placental infection.20 The 
present IL-6 findings are in fact similar to that we have previously reported in the ovine fetus 
subjected to repeated UCOs with severe acidemia whereby IL-6 levels remained unchanged, 
but IL-1β levels increased 2-fold at nadir pH.48 As such, a fetal systemic inflammatory 
response to the UCOs/severe acidemia is likely, but involving other cytokines than IL-6 or 
other substances suchas prostaglandins, at least for the time points herein studied. The LPS-
UCO animals received injections of LPS at 2 mg/h intraamniotic to simulate a low-grade 
bacterial infection as often observed in low-risk labouring patients at term with histologic 
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chorioamnionitis in the absence of clinical chorioamnionitis.20 This LPS dosing is similar to 
that of Kramer et al25 and approximately half of that used by Kallapur et al24 with both showing 
a rapid and sustained leukocytic infiltration in the extraplacental membranes lasting several 
days with associated increases in cytokine messenger RNA (mRNA) levels, although mainly 
for the first 24 hours. Plasma IL-6 began to increase in the LPS-UCO animals by the end of 
the severe UCOs and significantly so after 1 hour recovery and indicating a systemic 
inflammatory response in these animals. Although the effects of intraamniotic LPS alone were 
not studied which is a limitation, it is likely that the LPS-and UCO-induced fetal acidemia 
together contributed to this response since the increase in IL-6 was highly correlated with the 
degree of fetal acidemia at nadir pH in these animals. Additionally, another study in fetal sheep 
by Grigsby et al49 failed to show any increase in plasma or amniotic fluid IL-6 after intra-
amniotic LPS alone in a dosing similar to that used by Kallapur et al. However, in the study of 
Kramer et al25 with LPS dosing similar to the present study, cord plasma IL-6 levels at delivery 
were increased approximately 2-fold 5 hours post-LPS, although animals were 2 weeks 
younger and amniotic fluid IL-6 mRNA levels remained unchanged. This suggests interaction 
between the degree of fetal maturation and severity of endotoxin exposure in eliciting systemic 
inflammatory responses, which has been well described in the clinical literature relating to 
inflammation in preterm newborns.5 The additive effect of simulated low-grade infection is 
also consistent with our findings in labouring patients at term where umbilical cord levels for 
several cytokines including IL-6 are substantially increased in those patients with histologic 
chorioamnionitis.20 Although the cellular origin for the increase in plasma IL-6 seen remains 
unknown, it is likely that the extraplacental membranes are involved given the findings of 
Kramer et al25 and Kallapur et al,24 as well as the placental cotyledons given the greater impact 
here of UCO-induced changes in tissue perfusion and oxygenation.  
Amniotic fluid IL-1β and IL-6 in the normoxic-UCO and hypoxic-UCO animals were 
unchanged at 1 and 48 hours recovery from the UCOs/severe acidemia and indicating the 
absence of a placental and/or membrane inflammatory response for these cytokines or 
associated release into the amniotic cavity. As such, the neutrophil inflammatory response seen 
in the cotyledons of these animals was unlikely to involve secretion of cytokines to the amniotic 
cavity, which is not surprising since this response was confined to the zona intima away from 
the amniotic cavity. To the extent that plasma IL-1β was increased in these animals and 
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involved placental release as previously discussed, then cellular sources are again more likely 
to be away from the amniotic cavity. Of note, Nitsos et al50 also found amniotic fluid IL-6 as 
well as IL-8 to be unchanged in fetal sheep after intermittent UCOs over a 2-day period, 
although the degree of fetal acidemia was much less than in the present study, and cytokine 
levels were obtained at delivery 1 week after the UCOs. Amniotic fluid IL-1β and IL-6 in the 
LPS-UCO animals were increased at 1 and 48 hours recovery and markedly so for IL-1β at 48 
hours, albeit with considerable variance that related to the degree of UCO-induced acidemia. 
This finding indicates a placental and/or membrane inflammatory response in these animals, 
the likely synergistic effect of LPS together with UCO-induced fetal acidemia in triggering this 
response, and again supports the placenta and/or membranes as a major contributor to the fetal 
inflammatory response with the related increase in plasma IL-6 levels. It is also of note that 
the amniotic fluid cytokine response in these animals was much greater and longer lasting than 
the plasma cytokine response, which might impact developmental events for organ systems 
exposed to amniotic fluid as well studied for the lung.24,25,51 In the study of Kramer et al25 with 
similar LPS dosing to the present study, amniotic fluid IL-1β mRNA levels were also increased 
from 24 hours to 7 days and indicating a differential response to that of IL-6, which as noted 
remained unchanged with LPS alone. Of interest, they also found an increase in inflammatory 
cells within the amniotic fluid which related to the increase in cytokine mRNA levels post LPS, 
again supporting the amniotic fluid as an important source of inflammatory stimulus for the 
fetus.25  
In this study, we determined that repetitive UCOs with severe acidemia in the ovine fetus will 
result in increased neutrophil infiltration of the zona intima of the cotyledon placenta, and when 
combined with intra-amniotic LPS, increased IL-1β and IL-6 within the amniotic fluid and IL-
6 within the fetal plasma. As such, repetitive UCOs with severe acidemia can induce a placental 
and/or membrane inflammatory response and more so with simulated low-grade infection and 
likely involving multiple cellular sources with the potential for cytokine release to the 
umbilical circulation. Variable-type FHR decelerations due to umbilical cord compression are 
the most common nonreassuring FHR pattern observed intrapartum1 and when frequent and/or 
severe have been associated with increased incidence of neonatal acidosis and nuchal cord at 
delivery,2,4 and in turn neurologic sequelae.3,52 Additionally, there is now considerable 
evidence that fetal/neonatal inflammation in response to perinatal infection5-7 and hypoxic 
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asphyxia at birth10-12 plays a causal role in brain injury of the newborn. The present findings 
in an animal model relevant to human labour with repetitive UCOs, leading to severe acidemia 
in the presence or absence of simulated infection, adds to this evidence confirming the potential 
for placental and/or membrane inflammation.    
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Chapter 3 
Repetitive Umbilical Cord Occlusions and Brain Inflammation-
Injury 
3.1 Introduction 
Fetal hypoxia with severe acidemia at birth, as indicated by arterial pH of < 7.001,2 is associated 
with an increased risk for hypoxic-ischemic encephalopathy (HIE) and longer term neurologic 
sequelae, including cerebral palsy (CP).3 Variable fetal heart rate (FHR) decelerations are the 
most common non-reassuring FHR pattern observed intrapartum4 and are indicative of acute 
fetal hypoxemia due to compression of the umbilical cord during contractions.4,5 When 
frequent and/or severe they have been associated with an increased incidence of neonatal 
acidosis, low Apgar scores, and nuchal cord at the time of delivery,6,7 and thereby risk for later 
adverse neurologic outcome. However, most infants with severe acidemia at birth will not have 
longer term sequelae, suggesting that an infant’s susceptibility to hypoxic-acidemic brain 
injury may be influenced by a variety of factors in addition to the degree of birth asphyxia.8  
Both epidemiological and clinical studies have suggested that elevated pro-inflammatory 
cytokines through the course of infection are associated with an increased risk for perinatal 
brain injury, whether antenatal with chorioamnionitis or postnatal in the neonate.9  Subsequent 
animal-based studies with induced perinatal infection/inflammation have further supported the 
contributory role of pro-inflammatory cytokines and inflammatory cells in perinatal brain 
injury,9-11 and have also suggested that hypoxia and inflammation may act synergistically in 
the pathogenesis of brain injury.9,12,13 Hypoxia alone can also trigger an inflammatory response 
in the fetus, as indicated in both clinical and experimental studies showing that newborns with 
HIE can have elevated pro-inflammatory cytokines in the absence of infection.9,14-16 
Furthermore, pro-inflammatory cytokines have also been implicated in the development of 
brain injury due to chronic intrauterine hypoxia leading to fetal growth restriction.17 These data 
together indicate that intrauterine infection, acute asphyxia intrapartum, and chronic hypoxia 
during the antenatal period can induce an inflammatory response in the fetus which can act 
concomitantly and contribute to perinatal brain injury. 
Microglia are the resident immune cells within the brain, which can become activated in 
response to injury or infection, and have been shown to increase in number with fetal/neonatal 
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hypoxia and inflammation.17-19 Mast cells are another immune cell normally found sparsely 
within the developing brain, but are able to cross the blood-brain-barrier and also increase in 
number in response to hypoxic-ischemic insults.20,21 We have previously shown in the near-
term ovine fetus that repetitive umbilical cord occlusions (UCOs) with worsening acidemia 
will lead to an inflammatory response within the brain as indicated by elevated numbers of 
microglia and mast cells at 24 hours of recovery.22 We therefore hypothesized that repetitive 
UCOs with severe fetal acidemia and leading to an inflammatory response within the brain, 
will consequently result in increased brain injury. In the present study we therefore examined 
brain inflammation as measured by changes in microglia and mast cell number, and brain injury 
as measured by the presence of cellular necrosis and apoptosis at 48 hours of recovery from 
repetitive UCOs with severe acidemia in the near-term ovine fetus. We also examined the 
additional impact on brain inflammation and injury of lower oxygenation and low-grade 
bacterial infection as might be seen clinically during labour with fetal growth restriction and 
placental chorioamnionitis.23-25  
3.2 Materials and Methods 
3.2.1 Surgical Preparation and Experimental Procedure 
The data obtained in this chapter were from the same animals used in chapter 2.  Thirty mixed 
breed ewes were surgically instrumented at 124-128 days gestation (term = 147 days), then 
subjected to the repetitive UCO protocol or served as tissue controls for histological 
examination of the fetal brains. Anesthesia, surgical preparation, post-operative care and 
experimental procedure have previously been described in detail.26,27 Briefly, under general 
anesthesia polyvinyl catheters were placed in the maternal femoral vein for administering 
fluids and antibiotics and for blood sampling, in the fetal left and right brachiocephalic arteries 
for blood sampling and pressure recordings, the right brachiocephalic vein for administering 
antibiotics, and the amniotic cavity for amniotic fluid sampling and pressure recordings. 
Stainless-steel electrodes were placed biparietally to monitor fetal electrocortical (ECOG) 
activity and on the chest to monitor fetal electrocardiographic (ECG) activity. In experimental 
animals an inflatable occluder cuff was placed around the proximal portion of the umbilical 
cord. Animals were allowed to recover for 4 days during which antibiotics were administered 
and maternal and fetal blood samples were taken for blood gases and pH each day. Animal 
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care followed the guidelines of the Canadian Council on Animal Care and was approved by 
the University of Western Ontario Council on Animal Care. 
Animals were divided retrospectively into 4 groups based upon post-surgical fetal blood 
oxygen status. This was determined by averaging the arterial O2 saturation of blood samples 
taken on each of the 4 post-op recovery days, as well as at baseline on the day of the UCO 
experimental study. Fetuses with average baseline arterial O2 saturation of < 55% comprised a 
low oxygen or hypoxic-UCO group (n=5), since this level of oxygenation has been used to 
denote decreased oxygenation/spontaneous hypoxemia in the near-term ovine fetus.28,29 The 
remaining fetuses with average baseline arterial O2 saturation ≥ 55% were divided into a 
normoxic-UCO group (n=9), lipopolysaccharide (LPS)-UCO group (n=6), and control group 
(n=10). LPS was administered via hourly intra-amniotic injections of 2 mg/hr beginning 1 hour 
prior to the first UCO and continuing through the period of repetitive UCOs to simulate a low-
grade bacterial infection in LPS-UCO animals.30,31 The control group consisted of normoxic 
fetuses that underwent surgical preparation but were not subjected to UCOs. These animals 
were used as tissue controls for histological examination of the fetal brains. 
UCOs were induced by inflating occluder cuffs with varying volumes of saline, targeting FHR 
decelerations of 30, 60, and 90 beats per minute (bpm) corresponding to umbilical blood flow 
reductions of approximately 50%, 75%, and 100%, and thereby “mild-partial”, “moderate-
partial”, and “severe-complete” UCOs, respectively.32 All UCOs were 1 minute in duration 
and occurred every 2.5 minutes. A data acquisition and analysis system was used to record 
fetal arterial blood pressure, heart rate and amniotic pressure, with FHR triggered and 
calculated online from arterial pressure systolic peaks. After a 1-2 hour baseline control period, 
experimental fetuses were subjected to repetitive UCO series consisting of 1 hour of mild-
partial, 1 hour of moderate-partial, and up to 2 hours of severe-complete UCOs. UCOs were 
discontinued if fetal arterial pH dropped below 7.00, or after 2 hours of severe-complete UCOs. 
Animals were then allowed to recover for 48 hours at which time they were euthanized. 
Fetal arterial blood samples (1 mL) were taken at baseline, at the end of a representative UCO 
from each UCO series, every 20 minutes between UCOs, and after 1, 24, and 48 hrs of 
recovery. These blood samples were analyzed for blood gases, pH, glucose and lactate using 
an automated blood gas analyzer.26 Additional blood samples (3 mL) were collected at baseline 
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prior to UCOs, immediately after the final UCO, and at 1 and 48 hours of recovery, and 
processed for later analysis of pro-inflammatory cytokines.26    
3.2.2 Tissue Histochemical Analysis                      
Fetal brains were perfusion fixed immediately after animals were euthanized. Briefly, the fetal 
carotid artery and jugular vein were cannulated and the brain was perfused with 500 mL of 
cold saline followed by 500 mL of 4% paraformaldehyde.  The brain was then removed and 
immersed in 4% paraformaldehyde for 24 hours, then in fresh phosphate-buffered saline (PBS) 
for 3 days, followed by 70% ethanol for at least 7 days, and subsequently blocked and 
embedded in paraffin for histological analysis.   
Microglia within the brain were visualized using rabbit anti-Iba1 (1:500, Wako Chemicals 
USA, Richmond, VA) (Cat No. 019-19741, Lot No. lac4357) as the primary antibody along 
with a Vectastain Elite Kit (Vector Laboratories, Burlingame, CA).  Tissue sections were 
deparaffinized with three 5-minute washes in xylene, then rehydrated in a series of ethanol 
baths (100%, 100%, 90%, 90%, 70%) lasting 2 minutes each.  Tissue sections were then rinsed 
once in pure water for 5 minutes followed by two 5-minute washes in PBS.  For antigen 
retrieval, tissues were boiled in 10 mM citrate buffer for 30 minutes, cooled to room 
temperature for 30 minutes, then rinsed with two 5-minute washes in PBS.  Endogenous 
peroxidase activity was quenched by incubating tissues in 3% H2O2 (Fischer Scientific, 
Ottawa, ON) for 10 minutes followed by two 5-minute washes in PBS.  Endogenous biotin 
was blocked by incubating tissues in avidin solution followed by biotin solution for 15 minutes 
each.  To reduce non-specific staining, slides were incubated in Background Sniper (Biocare 
Medical, Concord, CA) for 7 minutes at room temperature then rinsed in PBS.  Tissue sections 
were then incubated in diluted primary antibody overnight (~20 hours) at 4°C, rinsed with three 
5-minute washes in PBS, incubated with secondary antibody (biotinylated goat anti-rabbit IgG) 
for 30 minutes at room temperature, and again rinsed with three 5-minute washes in PBS.  
Tissue sections were then incubated with streptavidin-peroxidase solution for 45 minutes at 
room temperature, rinsed with three 5-minute washes in PBS, and finally incubated with 
diaminobenzidine (Biocare Medical) for exactly 2 minutes to develop the stain.  Tissue sections 
were then dehydrated in a series of ethanol baths (70%, 70%, 90%, 100%, 100%) followed by 
3 5-minute washes in xylene and finally cover-slipped using Permount (Fischer Scientific). 
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Mast cells within the brain were identified by staining with toluidine blue.  Tissue sections 
were deparaffinized as noted, rinsed once in pure water for 5 minutes followed by two 5-minute 
washes in PBS, then immersed in toluidine blue solution (5 mg/ml toluidine blue in 0.1M HCl) 
for 10 minutes.  Sections were rinsed under running water for 5 minutes before a quick (10 
sec) dip in acid alcohol (0.5 mL of glacial acetic acid in 200 mL of 95% ethanol), then 
dehydrated, and cover-slipped as noted. 
Necrotic cell injury in the brain was studied by staining with H&E.  Tissue sections were 
deparaffinized as noted, then rinsed once in pure water for 5 minutes before being immersed 
in Harris’s Modified Haematoxylin stain (Fisher Scientific) for 10 seconds.  Stain was 
differentiated in 1% acid ethanol (2 mL HCl in 198 mL 70% ethanol) for approximately 1 
second, and then flushed under running water for 1 minute. Next, sections were stained with 
eosin (1% eosin Y in 95% ethanol and 0.5% glacial acetic acid, Fisher Scientific) for 
approximately 1 second.  Tissue sections were then dehydrated and cover-slipped as noted.  
Apoptotic cell injury in the brain was visualized using rabbit anti-cleaved-caspase-3 (1:500, 
Cell Signaling Technology, Danvers, MA) as the primary antibody along with a Vectastain 
Elite Kit (Vector Laboratories, Burlingame, CA) and using the same protocol as with the 
staining of microglia. The presence of DNA fragmentation within cells was additionally 
determined using the TUNEL assay method as a second measure of apoptosis (Apoptag Red 
In Situ Apoptosis Detection Kit, Millipore, Billerica, MA).  Tissue sections were 
deparaffinized as noted. After equilibrating in PBS for 5 minutes, tissues were incubated with 
proteinase K (20 μg/mL) for 15 minutes at room temperature, and then rinsed twice in PBS for 
5 minutes each.  Tissue sections were then covered with the provided equilibration buffer for 
~2 minutes then incubated with terminal deoxynucleotidyl transferase enzyme (TdT enzyme) 
for 1 hour at 37° C.  Enzyme activity was stopped by incubating the slides with the provided 
stop/wash buffer for 10 minutes at room temperature.  Slides were rinsed 3 times in PBS, and 
then incubated with rhodamine-conjugated anti-digoxigenin antibody for 30 minutes at room 
temperature.  Excess antibody was removed by 4 2-minute washes in PBS.  Tissues were 
counterstained in 1 μL/mL HOECHST 33342 (Life Technologies, Carlsbad, CA) for 4 minutes, 
then rinsed twice in PBS for 5 minutes each.  Tissues were cover-slipped using Pro-Long Gold 
Anti-fade (Life Technologies)) and stored at 4°C.  
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All analysis was done on coronal brain sections taken at the level of the mammillary bodies.  
Brain regions analyzed included the parasagittal grey matter, periventricular white matter, 
thalamus, and hippocampus regions CA1, CA3, and dentate gyrus.  Grey matter regions were 
further divided into layers 1-3 and layers 4-6 for analysis, but results were combined for these 
sub-regions when no differences were found.  Images were captured using a Leica DMRB 
transmitted light microscope (Leica-Microsystems, Wetzler, Germany) at 400x magnification.  
Identical illumination settings were used for all brain regions to allow for comparisons between 
regions as well as within regions.  For all experiments, a minimum of 4 HPFs per brain region 
were captured.  Microglia were identified by their characteristic morphology and dark, 
contiguous cytoplasmic staining and counted manually (Figure 3.1). Mast cells were identified 
by the metachromatic staining of secretory granules within their cytoplasm and again counted 
manually with the choroid plexus and leptomeninge regions additionally assessed (Figure 3.1). 
For caspase-3 analysis, image analysis software (Image Pro Plus 6.0, Media Cybernetics, Silver 
Spring, MD) was used to automatically count positively stained cells (Figure 3.2). Thresholds 
were set manually to include all cells with DAB-stained cytoplasm while at the same time 
ensuring no signal was scored as positive within negative control slides. For TUNEL analysis, 
a Zeiss fluorescence microscope was used to capture images (Figure 3.2).  Image analysis 
software (Image Pro Plus 6.0, Media Cybernetics) was used to automatically count positively 
stained cells. Due to autofluorescence of red blood cells in nearly all wavelengths, cells were 
additionally filtered by size. Necrotic appearing cells were identified by their characteristic 
morphology with eosinophilic cytoplasm and pyknotic nuclei and again scored manually 
(Figure 3.2).  Each HPF was scored on a 5-point scale based on the estimated percentage of 
necrotic appearing cells; with 0 = 0% necrotic cells, 5 = 1%-10% necrotic cells, 30 = 11%-
50% necrotic cells, 70 = 51%-90% necrotic cells, 95 = 91%-100% necrotic cells as previously 
reported.33 All tissue slides were coded with the experimenter blinded to animal treatment 
group. 
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Figure 0.1. Representative photomicrographs (400X) of brain sections, A from the thalamus 
following anti-IBA1 immunohistochemistry showing microglia with dark contiguous staining 
(arrows); and B from the choroid plexus stained with toluidine blue showing mast cells 
characterized by their large metachromatic secretory granules within the cytoplasm. Scale bar 
= 20 μm.      
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Figure 3.1. Representative photomicrographs (400X) of brain sections, A from the 
periventricular white matter following anti-cleaved-caspase3 immunohistochemistry and 
counterstained with hematoxylin showing contiguous dark brown cytoplasmic staining 
indicating the presence of cleaved-caspase3 (arrows); B from the dentate gyrus stained 
using the TUNEL assay method (red) and counterstained using Hoechst (blue) with the red 
fluorescence indicating DNA fragmentation and the blue fluorescence indicating normal 
cell nuclei; and C from the grey matter stained with H&E showing necrotic appearing 
neurons identified by their eosinophilic cytoplasm and loss of nuclear detail (arrow). Scale 
bar = 20μm. 
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3.2.3 Data Analysis 
Differences in microglia, mast cell, cell necrosis, cleaved-caspase-3 positive, and TUNEL 
positive cell counts among the four experimental groups were analyzed using a one-way 
analysis of variance (ANOVA) test (Kruskal–Wallis) with Dunn’s posttest for comparing each 
experimental group to the control group.  Comparisons between brain regions were done using 
a one-way repeated measures ANOVA test (Friedman) with Dunn’s posttest.  All statistical 
analysis was done using Graphpad Prism (Graphpad Software, La Jolla, CA).  All values 
shown are expressed as means ± SEM.  Statistical significance was assumed for p < 0.05. The 
ECOG, ECG, FHR, blood metabolite and cytokine findings have been reported 
separately.26,34,35   
3.3 Results  
3.3.1 Fetal Arterial Oxygen Saturation, Blood Gases, pH and Lactate 
Arterial oxygen saturation, blood gas, pH and lactate findings have been reported in Chapter 
3, section 3.3.2.  Please refer to Figure 2.4 (oxygen saturation, blood gas, pH) and Figure 2.5 
(glucose and lactate) for these results.                  
3.3.2 Fetal Brain Inflammation 
Microglia cell counts were analyzed at 48 hours of recovery after the repetitive UCOs as a 
measure of the brain inflammatory response.  In the control group animals, regional differences 
were evident with the highest number of microglia in the white mater at 13.4 ± 1.4 cells/HPF, 
which was significantly higher than that of the grey matter, hippocampal CA1, and thalamus 
(all p < 0.05) (Figure 3.3).  While this distribution of microglia cells across regions was also 
seen in the three UCO experimental groups, there were no significant differences for each brain 
region between the UCO group values compared to respective control values (Figure 3.3). 
Mast cell distribution at 48 hours of recovery after the repetitive UCOs was additionally 
analyzed as a second marker of inflammation within the brain.  Of note, mast cells were only 
found within the thalamus, the choroid plexus, and the leptomeninges. In the control group 
animals, regional differences were again evident with the highest number of mast cells in the 
choroid plexus at 0.9 ± 0.2 cells/HPF, which was significantly higher than in the leptomeninges 
at 0.1 ± 0.06 (p < 0.05) but not the thalamus at 0.3 ± 0.04 (Figure 3.4). While this hierarchal 
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distribution of mast cells across brain regions was generally seen in the three UCO groups, 
there again were no significant differences between any of the UCO and respective control 
group values (Figure 3.4).  
3.3.3 Fetal Brain Injury 
The presence of necrotic appearing cells at 48 hours of recovery after the repetitive UCOs was 
analyzed as a measure of overt cell injury within the brain.  In the control group animals, low 
levels of necrotic-appearing cells were observed being somewhat higher and significantly 
different from zero in the parasagittal grey matter, dentate gyrus, and thalamus (Figure 3.5). In 
the three UCO groups, low levels of necrotic-appearing cells were again noted, but none of 
these experimental groups had values that were significantly changed compared to respective 
control values (Figure 3.5).  
The presence of cleaved caspase-3 positive cells and TUNEL positive cells were analyzed as 
markers of apoptosis within the brain and thereby further measures of overt brain injury.  In 
the control group animals, regional differences were evident with the number of cleaved 
caspase-3 positive cells in the dentate gyrus at 24.2 ± 5.0 cells/HPF, significantly higher than 
in the grey matter, CA1, CA3, and thalamus (all p < 0.05) (Figure 3.6).  While this increase in 
dentate gyrus cell counts was also evident for the three UCO groups, there were no significant 
differences within each brain region between UCO group values, compared to  
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Figure 3.2. Bar graph of IBA1 positive microglia cells/high-power field (HPF) within the 
different brain regions of the control (open bars) and umbilical cord occlusion (UCO) (shaded 
bars) animal groups. GM = parasagittal grey matter, WM = periventricular white matter, DG 
= dentate gyrus, Th = thalamus. Values are mean ± SEM. Control, n = 10; Normoxic-UCO, 
n = 9; Hypoxic-UCO, n = 5; LPS-UCO, n = 5. 
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Figure 3.3. Bar graph of mast cells/high-power field (HPF) within the different brain regions 
of the control (open bars) and umbilical cord occlusion (UCO) (shaded bars) animal groups. 
Th = thalamus, CP = choroid plexus, LM = leptomeninges. Values are mean ± SEM. Control, 
n = 10; Normoxic-UCO, n = 9; Hypoxic-UCO, n = 5; LPS-UCO, n = 5. 
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Figure 3.4. Bar graph of percent necrotic appearing cells/high-power field (HPF) within the 
different brain regions of the control (open bars) and umbilical cord occlusion (UCO) (shaded 
bars) animal groups. GM = parasagittal grey matter, WM = periventricular white matter, DG 
= dentate gyrus, Th = thalamus. Values are mean ± SEM. Control, n = 10; Normoxic-UCO, 
n = 9; Hypoxic-UCO, n = 5; LPS-UCO, n = 5. 
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Figure 3.5. Bar graph of cleaved-caspase3 positive cells/high-power field (HPF) within the 
different brain regions of the control (open bars) and umbilical cord occlusion (UCO) (shaded 
bars) animal groups. GM = parasagittal grey matter, WM = periventricular white matter, DG 
= dentate gyrus, Th = thalamus. Values are mean ± SEM. Control, n = 10; Normoxic-UCO, 
n = 9; Hypoxic-UCO, n = 5; LPS-UCO, n = 5. 
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respective control values (Figure 3.6).  The presence of TUNEL positive cells indicating DNA 
fragmentation as another measure of cell apoptosis was considerably less than that found for 
cleaved caspase-3.  In the control group animals, very few cells were scored TUNEL positive 
with all brain regions having fewer than 0.10 cells/HPF and showing no regional differences 
(Figure 3.7).  While the normoxic-UCO animals had TUNEL positive cell counts that were 
little changed from that of the control values, the LPS-UCO animals had TUNEL positive cell 
counts that were significantly increased in the hippocampal CA1 and the dentate gyrus at 0.12 
± 0.05 and 0.15 ± 0.05 cells/HPF, respectively (both p < 0.05) (Figure 3.7).  Additionally, 
TUNEL positive cell counts in the CA1 region of the hypoxic-UCO group and the CA3 region 
of the LPS-UCO group were more than three-fold higher than respective control values, but 
these changes were not significant due to small animal numbers and population variance. 
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Figure 3.6. Bar graph of TUNEL positive cells/high-power field (HPF) within the different 
brain regions of the control (open bars) and umbilical cord occlusion (UCO) (shaded bars) 
animal groups. GM = parasagittal grey matter, WM = periventricular white matter, DG = 
dentate gyrus, Th = thalamus. * p < 0.05 compared to respective control value. Values are 
mean ± SEM. Control, n = 10; Normoxic-UCO, n = 9; Hypoxic-UCO, n = 5; LPS-UCO, n = 
5. 
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3.4 Discussion   
In the present study, near-term fetal sheep were subjected to repetitive UCOs of increasing 
severity leading to worsening acidemia as might be seen clinically during labour, with some of 
these animals also chronically hypoxic or subjected to low-grade inflammation as might be 
seen with fetal growth restriction and placental chorioamnionitis. We used a UCO paradigm 
consisting of 60-second UCOs occurring every 2.5 minutes, with 1 hour of mild-partial cord 
occlusions, followed by 1 hour of moderate-partial cord occlusions, then up to 2 hours of 
severe-complete cord occlusion. However, despite up to 4 hours of repetitive UCOs of 
worsening severity, 5 of the 20 UCO animals did not attain a severe degree of fetal acidemia 
with arterial pH < 7.00, although difficulty with complete occluder inflation was likely 
contributory in two of these animals. This differs from our previous study with 60-second 
UCOs of increasing frequency with 1 hour of complete UCOs every 5 minutes, followed by 1 
hour of complete UCOs every 3 minutes, and then up to 2 hours of complete UCOs every 2 
minutes with all 10 of the animals studied attaining an arterial pH < 7.00 within this time 
frame.22 Moreover, the nadir arterial pH reached in the present study with up to 4 hours of 
repetitive UCOs of increasing severity at ~ 7.02 was somewhat higher than that previously 
seen with up to 4 hours of repetitive UCOs of increasing frequency at 6.90.22 Accordingly, our 
4 hour UCO paradigm with increasing severity resulted in less acidemia than that with 
increasing frequency. The major difference here is likely the time for recovery between 
complete occlusions at 90 and 60 seconds, respectively, during the severe UCOs when much 
of the pH change was noted, and indicating the importance of this variable in the progression 
of fetal acidemia.36  
Microglia are the innate immune cells of the central nervous system and are involved in the 
phagocytosis of cellular debris, and induction of neuronal cell death during normal 
development.37 However, when exposed to noxious stimuli such as inflammation and ischemia, 
microglia become activated which can lead to exacerbation of brain injury through the 
secretion of inflammatory mediators including reactive oxygen species, nitrous oxide, and pro-
inflammatory cytokines.38-41 In this regard, elevated microglia counts have been found within 
the dentate gyrus of human infants exposed to perinatal hypoxic-ischemia,42 and in the white 
matter of the mid-term and near-term ovine fetus exposed to either hypoxic-ischemia or 
systemic endotoxemia,43 and variably relating to the degree of brain injury. Additionally, we 
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have shown microglia counts to be increased in the white matter and hippocampus of the near-
term ovine fetus at 24 hours recovery from repetitive UCOs with severe fetal acidemia and 
indicating a local inflammatory response within the brain to this insult.22 In the present study, 
we found a regional hierarchy with microglia more numerous within the white matter for all 
four study groups, which is consistent with our previous report.22 However, no change in 
microglia counts was seen for any of the brain regions at 48 hours recovery from the repetitive 
UCOs, either alone or in conjunction with pre-existing intrauterine hypoxia or low-grade 
inflammation, which differs from our previous findings.22 Since the brain tissues were 
collected at 48 hours after the UCOs/LPS administration, any microglia inflammatory response 
from these stimuli might now be lessened or no longer evident compared to that we previously 
noted at 24 hours recovery from repetitive UCOs.22 However, this seems unlikely since chronic 
endotoxin exposure in fetal sheep results in persistence of microgliosis within the subcortical 
white matter for several days after the LPS administration.44 More likely then is that the degree 
of fetal acidemia resulting from the repetitive UCOs with nadir pH at ~ 7.00, 7.01, and 7.07 
for the normoxic-UCO, hypoxic-UCO, and LPS-UCO groups, respectively, was not sufficient 
to evoke an  inflammatory response with increased microglia activation as in our previous 
study where nadir pH reached 6.90.22 This presumption is supported by the lack of a systemic 
inflammatory response in the normoxic- and hypoxic-UCO animals with arterial IL-6 levels 
also unchanged,26 which can increase blood-brain barrier permeability to monocytes and other 
cellular and molecular inflammatory mediators.9,11 While arterial IL-6 levels were increased at 
1 hour recovery in the LPS-UCO animals and correlated with the degree of acidemia attained,26 
there was still no increase in brain microglia as measured 2 days later, although cell counts in 
the subcortical white matter were the highest amongst the 4 animal groups.   
Mast cells are widely recognized as mediators of inflammatory processes through the secretion 
of a variety of biological molecules including histamine, prostaglandins, and cytokines, and 
have been implicated in the pathogenesis of inflammatory brain injury with increasing 
evidence for such with perinatal hypoxic-ischaemia.20,22,45,46  In the immature rat brain mast 
cells are initially concentrated in the leptomeninges and choroid plexus, and following 
hypoxic-ischaemic insult show increased migration into the thalamus as well as degranulation 
supporting the contention that mast cells mediate inflammatory brain injury20. We also found 
mast cells to be increased in the choroid plexus and thalamus of the near-term ovine fetus at 
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24 hours recovery from repetitive UCOs/severe acidemia22 further supporting a causal role for 
mast cells in newborn HIE. In the present study, mast cells were more numerous in the choroid 
plexus for all four study groups, which is consistent with our previous report.22 However, 
similar to the microglia findings, no change in mast cell counts was seen for any of the brain 
regions studied in the normoxic-UCO, hypoxic-UCO or LPS-UCO groups when compared to 
controls. The reasons for this differential mast cell response from that of our previous UCO 
study22 are likely to be the same as discussed for the differential microglia response, and 
implicate a coupling of both of these in the brain’s local inflammatory response to perinatal 
hypoxic-acidemia along with some degree of systemic inflammation. 
The current study showed low levels of necrotic-appearing cells in brain regions of the control 
group animals as identified using H&E morphology similar to that we33 and others47 have 
reported in studies of induced hypoxia in sheep. As such, it is possible that biologic low levels 
of necrosis exist in the developing brain, or alternatively, are the result of the inherent 
subjectivity of the scoring procedure. Additionally, the morphologic changes associated with 
standard H&E methods of identifying necrosis, including cell shrinkage and eosinophilia, can 
also occur as processing artifacts or nonlethal alterations in cellular morphology.48 Despite up 
to 4 hours of repetitive UCOs in the normoxic-, hypoxic-, and LPS-UCO group animals, and 
resulting in severe acidemia in most of these animals with nadir arterial pH at or below 7.00, 
there was no significant effect on measured levels of necrotic-appearing cells within the brain 
when compared to respective control group values. In adult studies of cerebral ischemia, there 
is a reproducible sequence of changes, with an upper ischemic flow threshold of synaptic 
transmission failure but the maintenance of energy levels and a lower ischemic flow threshold 
of membrane failure that indicates energy depletion and is associated closely with the 
development of structural cell damage.49 In studies of cerebral metabolism and ECOG activity 
in fetal sheep subjected to UCOs, we have shown the ability to rapidly enact mechanisms to 
protect energy levels for membrane integrity by increasing cerebral blood flow, substrate 
extraction, and anaerobic metabolism and decreasing non-essential energy usage when oxygen 
availability is acutely limited.50,51 Of note, the animals herein studied also showed ECOG 
amplitude suppression during the UCOs with worsening acidosis indicating a decrease in 
synaptic energy use and with no difference in the timing for this between the UCO groups.35 
Accordingly, the near-term ovine fetal brain appears able to tolerate repetitive UCOs with 
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severe acidemia and nadir pH ~ 7.00 with no increase in overt necrotic cell injury, presumably 
through adaptive metabolic mechanisms such that the lower ischemic flow threshold of 
membrane failure with energy depletion was likely not reached.     
Apoptosis, or programed cell death, is normally evident during the fetal/neonatal period of 
brain development in post-mitotic cells coincident with neuronal differentiation and 
synaptogenesis, which may relate to the establishment of axonal-target connectivity and 
competition for trophic factors produced by target cells.52 Apoptosis in the fetal/neonatal brain 
can also be activated pathologically by hypoxic-acidemia resulting in selective neuronal loss, 
which can be exacerbated by chronic hypoxia.53,54 The process of apoptosis involves the 
stimulation of intrinsic and/or extrinsic signaling pathways leading to the cleavage of caspase-
3 into its active form, which together with other effector caspases targets multiple proteins for 
proteolysis resulting in the fragmentation of the cell’s DNA and the dismantling of diverse cell 
structures.55,56 Accordingly, immunoreactivity for cleaved caspase-3 as the active form of this 
effector caspase, and using the TUNEL assay method to detect fragmented DNA strands have 
become established markers of cellular apoptosis as used in the present study. In the control 
group animals, low levels of cleaved caspase-3 positive cells were seen in the brain regions 
studied but were 3-fold higher in the dentate gyrus, and with all of these levels considerably 
higher than the respective levels for apoptotic activity as measured using TUNEL. This higher 
level of apoptotic activity in the near-term ovine fetal brain as measured using cleaved caspase-
3 has also been reported by others,57 and likely relates in part to cleaved caspase-3 being 
evident earlier and longer during apoptotic cell death than DNA fragmentation which is a 
terminal event. However, recent study shows that caspase-3 activation does not always lead to 
DNA fragmentation, especially in the developing brain where it can play a nonapoptotic role 
in cellular differentiation and remodeling or neuroplasticity through selective removal of 
existing synaptic connections.56 The present findings thereby suggest a substantial role for 
activated caspase-3 in regulating nonapoptotic processes in the developing brain and moreso 
in the dentate gyrus, consistent with the high level of neuroplasticity seen here into adulthood 
with a constant state of competing neurodegeneration and neurogenesis.58   
Despite up to 4 hours of repetitive UCOs in the normoxic- and hypoxic-UCO groups and severe 
acidemia in most of these animals, there again was no significant effect on measured levels of 
either cleaved caspase-3 or TUNEL positive cells although the latter is likely to better reflect 
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apoptotic cell death within the developing brain as noted. While it has been held that brain 
injury in response to hypoxia is more likely to be apoptotic with milder insult and necrotic with 
severe insult, it is becoming evident that both occur as a continuum of cell death in proportion 
to the severity of hypoxic insult.55 As such, the adaptive metabolic mechanisms enacted to 
protect against necrotic cell death are also likely to protect against apoptotic cell death in the 
normoxic- and hypoxic-UCO groups as studied. Moreover, the balance in the expression of 
anti- and pro-apoptotic genes determines apoptotic triggering in response to hypoxia, and it is 
possible that the mild- and moderate-partial UCOs have altered this in favour of anti-apoptotic 
gene expression by hypoxic conditioning, thereby increasing tolerance to the severe-complete 
UCOs.55 However, the number of TUNEL positive cells was increased in the hippocampal 
CA1 and dentate gyrus regions for the LPS-UCO group animals compared to respective control 
values. While these animals did not show any evidence of a brain inflammatory response as 
studied, they did show an increase in plasma and amniotic fluid inflammatory cytokines that 
related to the degree of UCO-induced acidemia and indicating a fetal/placental inflammatory 
response.26 Accordingly, it is likely that the LPS- and UCO-induced systemic inflammation 
together with the fetal hypoxic-acidemia contributed to the increased brain apoptosis with the 
relative expression of anti- and pro- apoptotic genes accounting for the regional differences in 
vulnerability.55 This conjecture is also consistent with the synergistic interaction between 
inflammation and hypoxia in the pathogenesis of perinatal brain injury reported by others.9,12,13 
However, intra-amniotic LPS dosing alone similar to the present study has shown apoptotic 
cell counts in the ovine fetal brain to be selectively increased at 48 hours,59 although a second 
study with lower LPS dosing but over 28 days showed no impact here.60 Since the effects of 
intra-amniotic LPS alone were not studied which is a limitation, it is possible the apoptotic 
changes seen were primarily the result of the LPS, although it seems likely that the repetitive 
UCOs were also contributory given the relationship to the degree of resultant acidemia as 
noted.     
In the present study, we have used an animal model relevant to human labour with repetitive 
UCOs leading to worsening fetal acidemia in the presence or absence of chronic hypoxia or 
simulated infection. Despite up to 4 hours of repetitive UCOs and severe acidemia in most of 
these animals with arterial pH to 7.00, there was no significant effect on measures of brain 
injury or inflammation, except in the LPS-UCO animals where TUNEL positive cells were 
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increased in the hippocampus. As such, the near-term ovine fetal brain shows remarkable 
tolerance for these cord occlusion insults and likely involving adaptive metabolic mechanisms, 
despite the severe acidemia noted.50,51 This is consistent with the clinical literature whereby 
most infants with severe acidemia and arterial pH to 7.00 at birth will still be without 
neurologic complications.1-3 However, in similar studies of repetitive UCOs but leading to 
more severe fetal acidemia with nadir pH to ~ 6.90, we found increased brain inflammation at 
24 hours,22 while de Haan et al61 found increased infarction and selective neuronal loss at 72 
hours. Accordingly, there is probably a narrow threshold between a degree of hypoxic-
acidemia associated with no sequellae, and an insult causing cerebral impairment or even 
death, with the critical issue likely the maintenance of blood pressure and thereby tissue 
perfusion including that to the brain.51,61 Moreover, this threshold in relation to worsening 
acidemia may be lowered in conjunction with fetal inflammation as previously proposed9,12,13 
and further supported by the present findings. 
       
  
 75 
3.5 References 
1. Goldaber KG, Gilstrap LC, Leveno KJ, Dax JS, McIntire DD. Pathologic fetal 
acidemia. Obstet Gynecol. 1991;78:1103–1107. 
2. American College of Obstetricians. Neonatal encephalopathy and neurologic 
outcome, second edition. Obstet Gynecol. 2014;123(4):896-901. 
3. Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE. A systematic review 
of the role of intrapartum hypoxia-ischemia in the causation of neonatal 
encephalopathy. Am J Obstet Gynecol. 2008;199(6):587-95. 
4. American College of Obstetricians and Gynecologists. Fetal heart rate patters: 
Monitoring, interpretation, and management; technical bulletin no. 207. Washington, 
DC: The College; 1995. 
5. Ball RH, Parer JT. The physiologic mechanisms of variable decelerations. Am J 
Obstet Gynecol. 1992;166(6 Pt 1):1683-8; discussion 1688-9. 
6. Anyaegbunam A, Brustman L, Divon M, Langer O. The significance of antepartum 
variable decelerations. Am J Obstet Gynecol. 1986;155(4):707-10. 
7. Hoskins IA, Frieden FJ, Young BK. Variable decelerations in reactive nonstress tests 
with decreased amniotic fluid index predict fetal compromise. Am J Obstet Gynecol. 
1991;165(4 Pt 1):1094-8. 
8. Winkler CL, Hauth JC, Tucker JM, Owen J, Brumfield CG. Neonatal complications 
at term as related to the degree of umbilical artery acidemia. Am J Obstet Gynecol. 
1991;164: 637–641. 
9. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, Espinoza J, 
and Hassan SS. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 
2007;50: 652–683. 
10. Nitsos I, Rees SM, Duncan J, Kramer BW, Harding R, Newnham JP, and Moss TJ. 
Chronic exposure to intra-amniotic lipopolysaccharide affects the ovine fetal brain. J 
Soc Gynecol Investig. 2006;13:1–9. 
11. Duncan J, Cock M, Suzuki K, Scheerlinck JP, Harding R, Rees S. Chronic Endotoxin 
Exposure Causes Brain Injury in the Ovine Fetus in the Absence of Hypoxemia. J Soc 
Gynecol Investig. 2006;13:87–96. 
12. Eklind S, Mallard C, Leverin AL, Blomgren K, Mattsby-Baltzer I, Hagberg H. 
Bacterial endotoxin sensitizes the immature brain to hypoxic--ischaemic injury. Eur J 
Neurosci. 2001;13:1101–1106. 
13. C Coumans ABC, Middelanis J, Garnier Y, Vaihinger H-M, Leib SL, Duering Von 
MU, Hasaart THM, Jensen A, Berger R. Intracisternal application of endotoxin 
 76 
enhances the susceptibility to subsequent hypoxic-ischemic brain damage in neonatal 
rats. Pediatr Res. 2003;53(5):770-5. 
14. Silveira RC, Procianoy RS. Interleukin-6 and tumor necrosis factor-α levels in plasma 
and cerebrospinal fluid of term newborn infants with hypoxic–ischemic 
encephalopathy. J Pediatr. 2003;143:625–629. 
15. Chiesa C, Pellegrini G, Panero A, De Luca T, Assumma M, Signore F, Pacifico L. 
Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal 
asphyxia. Eur. J. Clin. Invest. 2003;33(4):352–358. 
16. Deng W. Neurobiology of injury to the developing brain. Nat Rev Neurol. 
2010;6:328–336. 
17. Hutton LC, Castillo-Meléndez M, Smythe GA, Walker DW. Microglial activation, 
macrophage infiltration, and evidence of cell death in the fetal brain after 
uteroplacental administration of lipopolysaccharide in sheep in late gestation. Am J 
Obstet Gynecol. 2008;198:117.e1–117.e11. 
18. Kaur C, Rathnasamy G, Ling EA. Roles of activated microglia in hypoxia induced 
neuroinflammation in the developing brain and the retina. J Neuroimmune 
Pharmacol. 2013;8(1):66-78.  
19. Jin Y, Silverman AJ, Vannucci SJ. Mast Cell Stabilization Limits Hypoxic-Ischemic 
Brain Damage in the Immature Rat. Dev Neurosci. 2007;29:373–384. 
20. Silverman AJ, Sutherland AK, Wilhelm M, Silver R. Mast cells migrate from blood 
to brain. J Neurosci. 2000;20(1):401-8. 
21. Prout AP, Frasch MG, Veldhuizen RAW, Hammond R, Ross MG, Richardson BS. 
Systemic and cerebral inflammatory response to umbilical cord occlusions with 
worsening acidosis in the ovine fetus. Am J Obstet Gynecol. 2010;202:82.e1–9. 
22. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of 
preterm birth. Lancet. 2008;371:75–84. 
23. Becroft DMO, Thompson JMD, Mitchell EA. Placental Chorioamnionitis at Term: 
Epidemiology and Follow-Up in Childhood. Pediatr Dev Pathol. 2010;1:282–290. 
24. Soothill PW, Nicolaides KH, Campbell S. Prenatal asphyxia, hyperlacticaemia, 
hypoglycaemia, and erythroblastosis in growth retarded fetuses. Br Med J (Clin Res 
Ed). 1987;294:1051–1053. 
25. Xu A, Matushewski B, Cao M, Hammond R, Frasch MG, Richardson BS. The Ovine 
Fetal and Placental Inflammatory Response to Umbilical Cord Occlusions with 
Worsening Acidosis. Reprod Sci. 2015. [Epub ahead of print] 
 77 
26. Green LR, Homan J, White SE, Richardson BS. Cardiovascular and metabolic 
responses to intermittent umbilical cord occlusion in the preterm ovine fetus. J Soc 
Gynecol Investig. 1999;6(2):56-63. 
27. Richardson BS, Carmichael L, Homan J, Patrick JE. Electrocortical activity, 
electroocular activity, and breathing movements in fetal sheep with prolonged and 
graded hypoxemia. Am J Obstet Gynecol. 1992;167(2):553-8. 
28. Gardner DS, Fletcher AJ, Bloomfield MR, Fowden AL, Giussani DA. Effects of 
prevailing hypoxaemia, acidaemia or hypoglycaemia upon the cardiovascular, 
endocrine and metabolic responses to acute hypoxaemia in the ovine fetus. J Physiol. 
2002;540(Pt 1):351-66. 
29. Kallapur SG, Willet KE, Jobe AH, Ikegami M, Bachurski CJ. Intra-amniotic 
endotoxin: chorioamnionitis precedes lung maturation in preterm lambs. Am J Physiol 
Lung Cell Mol Physiol. 2001;280(3):L527–L536.  
30. Kramer BW, Moss TJ, Willet KE, Newnham JP, Sly PD, Kallapur SG, Ikegami M, and 
Jobe AH. Dose and time response after intraamniotic endotoxin in preterm lambs. Am 
J Respir Crit Care Med. 2001;164(6):982-8. 
31. Itskovitz J, LaGamma EF, Rudolph AM. Heart rate and blood pressure responses to 
umbilical cord compression in fetal lambs with special reference to the mechanism of 
variable deceleration. Am J Obstet Gynecol. 1983;147(4):451–457.  
32. Rocha E, Hammond R, Richardson B. Necrotic cell injury in the preterm and near-term 
ovine fetal brain after intermittent umbilical cord occlusion. Am J Obstet Gynecol. 
2004;191:488–496. 
33. Durosier LD, Green G, Batkin I, Seely AJ, Ross MG, Richardson BS, and Frasch 
MG. Sampling rate of heart rate variability impacts the ability to detect acidemia in 
ovine fetuses near-term. Front Pediatr. 2014; 2: 38. 
34. Frasch MG, Durosier LD, Xu A, Cao M, Matushewski B, Keenliside L, Louzoun Y, 
Ross MG, Richardson BS. Adaptive shut-down of EEG activity predicts critical 
acidemia in the near-term ovine fetus. Physiological Reports. 2015, In press. 
35. Ross MG, Jessie M, Amaya K, Matushewski B, Durosier LD, Frasch MG, 
Richardson BS. Correlation of arterial fetal base deficit and lactate changes with 
severity of variable heart rate decelerations in the near-term ovine fetus. Am J Obstet 
Gynecol. 2013;208(4):285.e1-6. 
36. Marín-Teva JL, Cuadros MA, Martín-Oliva D, Navascués J. Microglia and neuronal 
cell death. Neuron Glia Biol. 2012;7:25–40. 
37. Yoshida T, Tanaka M, Sotomatsu A, Hirai S. Activated microglia cause superoxide-
mediated release of iron from ferritin. Neurosci Lett. 1995;190(1):21-4. 
 78 
38. Chao, C.C., Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia 
mediate neuronal cell injury via a nitric oxide mechanism. J Immunol. 
1992;149(8):2736-41. 
39. Giulian D, Baker TJ, Shih LC, Lachman LB. Interleukin 1 of the central nervous 
system is produced by ameboid microglia. J Exp Med. 1986;164(2):594-604. 
40. Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumor necrosis 
factor-alpha by microglia and astrocytes in culture. Brain Res. 1989;491(2):394-7. 
41. Del Bigio MR, Becker LE. Microglial aggregation in the dentate gyrus: A marker of 
mild hypoxic-ischaemic brain insult in human infants. Neuropathol Appl Neurobiol. 
1994;20(2):144-51. 
42. Mallard, C., Welin, A.-K., Peebles, D., Hagberg, H. and Kjellmer, I. White matter 
injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem 
Res. 2003;28(2):215-23. 
43. Duncan JR, Cock ML, Suzuki K, Scheerlinck JP, Harding R, Rees SM. Chronic 
endotoxin exposure causes brain injury in the ovine fetus in the absence of 
hypoxemia. J Soc Gynecol Investig. 2006;13(2):87-96. 
44. Lindsberg PJ, Strbian D, Karjalainen-Lindsberg ML. Mast cells as early responders in 
the regulation of acute blood&ndash;brain barrier changes after cerebral ischemia and 
hemorrhage. J Cereb Blood Flow Metab. 2010;30:689–702. 
45. Skaper SD, Giusti P, Facci, L. Microglia and mast cells: two tracks on the road to 
neuroinflammation. FASEB J. 2012;26(8):3103-17 
46. Keunen H, Blanco CE, van Reempts JL, Hasaart TH. Absence of neuronal damage 
after umbilical cord occlusion of 10, 15, and 20 minutes in midgestation fetal sheep. 
Am J Obstet Gynecol. 1997;176(3):515-20. 
47. Schmued LC, Albertson C, Slikker W Jr. Fluoro-Jade: A novel fluorochrome for the 
sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 
1997;751(1):37-46. 
48. Astrup J. Energy-requiring cell functions in the ischemic brain. Their critical supply 
and possible inhibition in protective therapy. J Neurosurg. 1982;56(4):482-97. 
49. Richardson BS, Carmichael L, Homan J, Johnston L, Gagnon R. Fetal cerebral, 
circulatory, and metabolic responses during heart rate decelerations with umbilical 
cord compression. Am J Obstet Gynecol. 1996;175(4 Pt 1):929-36. 
50. Kaneko M, White S, Homan J, Richardson B. Cerebral blood flow and metabolism in 
relation to electrocortical activity with severe umbilical cord occlusion in the near-
term ovine fetus. Am J Obstet Gynecol. 2003;188(4):961-72. 
 79 
51. Blaschke AJ, Staley K, Chun J. Widespread programmed cell death in proliferative 
and postmitotic regions of the fetal cerebral cortex. Development. 1996;122(4):1165-
74. 
52. Yue X, Mehmet H, Penrice J, Cooper C, Cady E, Wyatt JS, Reynolds EO, Edwards 
AD, Squier MV. Apoptosis and necrosis in the newborn piglet brain following 
transient cerebral hypoxia-ischaemia. Neuropathol Appl Neurobiol. 1997;23(1):16-25. 
53. Burke C, Sinclair K, Cowin G, Rose S, Pat B, Gobe G, Colditz P. Intrauterine growth 
restriction due to uteroplacental vascular insufficiency leads to increased hypoxia-
induced cerebral apoptosis in newborn piglets. Brain Res. 2006;1098(1):19-25. 
54. Banasiak KJ, Xia Y, Haddad GG. Mechanisms underlying hypoxia-induced neuronal 
apoptosis. Prog Neurobiol. 2000;62(3):215-49. 
55. D'Amelio M, Cavallucci V, Cecconi F. Neuronal caspase-3 signaling: not only cell 
death. Cell Death Differ. 2010;17(7):1104-14.  
56. Yawno T, Hirst JJ, Castillo-Melendez M, Walker DW. Role of neurosteroids in 
regulating cell death and proliferation in the late gestation fetal brain. Neuroscience. 
2009;163(3):838-47.  
57. Perederiy JV, Westbrook GL. Structural plasticity in the dentate gyrus- revisiting a 
classic injury model. Front Neural Circuits. 2013;7:17.  
58. Gavilanes AW, Strackx E, Kramer BW, Gantert M, Van den Hove D, Steinbusch H, 
Garnier Y, Cornips E, Steinbusch H. Chorioamnionitis induced by intraamniotic 
lipopolysaccharide resulted in an interval-dependent increase in central nervous 
system injury in the fetal sheep. Am J Obstet Gynecol. 2009;200(4):437.e1-8.  
59. Nitsos I, Newnham JP, Rees SM, Harding R, Moss TJ. The impact of chronic 
intrauterine inflammation on the physiologic and neurodevelopmental consequences 
of intermittent umbilical cord occlusion in fetal sheep. Reprod Sci. 2014;21(5):658-
70.  
60. De Haan HH, Gunn AJ, Williams CE, Gluckman PD. Brief repeated umbilical cord 
occlusions cause sustained cytotoxic cerebral edema and focal infarcts in near-term 
fetal lambs. Pediatr Res. 1997;41(1):96-104. 
  
 80 
Chapter 4 
4.1 Summary 
In this thesis we have used an animal model relevant to human labour with repetitive UCOs 
leading to worsening fetal acidemia in the presence or absence of chronic hypoxia or simulated 
infection.  To our knowledge this is the first study to look at the inflammatory response in the 
placenta in response to UCOs in fetal sheep. Despite up to 4 hours of repetitive UCOs and 
severe acidemia in most of these animals with arterial pH to 7.00, there was no significant 
effect on measures of brain injury or inflammation. However, the hypoxic insult did result in 
infiltration of neutrophils into the maternal zone of the cotyledons.  The link between UCO 
and neutrophil infiltration in the placenta was not elucidated, but may involve cytokines not 
studied in this thesis, or other biological molecules such as prostaglandins.  The placenta is a 
possible source of the pro-inflammatory cytokines IL-6 and IL-1β seen in the fetal circulation 
and amniotic fluid respectively in our study.  Further studies of the events occurring between 
the hypoxic insult and the infiltration of neutrophils in the placenta may identify new 
therapeutic targets or early markers of hypoxic brain injury. 
4.2 Limitations and Future Directions 
A limitation of this study is that it did not include an experimental group that was exposed to 
LPS alone, without UCOs and resulting acidemia. The effect of intraamniotic LPS on near-
term ovine fetuses have been previously studied by Gavilanes et al.1  Using a comparable 
dosage of 10 mg given at 123 days gestation, Gavilanes et al. found increased rates of apoptosis 
in the grey mater and hippocampus, as well as increased activated microglia in the 
hippocampus and caudate putamen after 48 hours1, showing that that intraamniotic LPS alone 
can have  significant and region dependent effects on brain injury and inflammation.    Thus, 
the inclusion of this additional study group may have given us valuable insight on the LPS-
UCO group.  Additionally, Gavilanes et al. used flow cytometry for analysis of brain tissues, 
which is a far more sensitive method compared to those use in the present study.  This may 
account for why they saw changes in apoptosis and activated microglia where we did not.  
In the present study, repetitive UCOs with severe acidemia resulted in elevated neutrophil 
numbers in the zona intima of the placenta, but additional exposure to intraamniotic LPS did 
not have an additive effect.  Since neutrophil infiltration into the fetal membranes is the 
 81 
hallmark of chorioamnionitis, it is surprising that intraamniotic LPS exposure did not result in 
increased neutrophil numbers.  This may be due to the fact that the extraplacental fetal 
membranes themselves were not analyzed but rather the fetal tissues adjacent to the cotyledons.  
Intraamniotic LPS exposure has been shown to cause increased cellular infiltration in the 
extraplacental fetal membranes2,3, so analysis of those tissues may yield useful data on the 
placental inflammatory response in the context of repetitive UCOs.    
An interesting finding in this study was the high levels of apoptosis in the near-term ovine fetal 
brain as measured using cleaved caspase-3, even in control animals.  This finding was not 
corroborated by the TUNEL analysis of the same specimens, possibly due the fact that cleaved 
caspase-3 is evident earlier and longer throughout apoptosis compared to DNA fragmentation, 
which is a terminal event. However, it is more likely that not all these cells positive for cleaved 
caspase-3 will proceed to complete apoptosis.  Studies have shown that in the developing brain, 
cleavage of caspase-3 can have nonapoptotic functions such as remodeling or pruning of 
existing neuronal connections with significance in early neuroplasticity, or may even have 
neuroprotective effects against ischemic insults .4-6  Indeed, high levels of cleaved caspase-3 
has been seen in the ovine fetus by other groups.7  While the function of cleaved of caspase-3 
in the near term ovine brain in unclear, the high levels present, especially in the dentate gyrus, 
suggests it has an important role in brain development, and may warrant further study. 
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4.3 Conclusions 
In this thesis, an ovine model of repetitive UCOs was used to investigate the effects of severe 
fetal acidemia as might be seen clinically during labour on the placental inflammatory response 
and subsequent brain injury in the ovine fetus.  Additionally, the effects of pre-existing chronic 
hypoxia or low-grade inflammation as might be seen with fetal growth restriction or histologic 
chorioamnionitis, were also examined. 
Repetitive UCOs in the ovine fetus leading to severe fetal acidemia results in a placental 
inflammatory response as shown by increased neutrophils in the placental zona intima and 
elevated IL-1B in the amniotic fluid.  When additionally exposed to intraamniotic LPS, a 
systemic fetal inflammatory response is seen as shown by elevated IL-6 in the fetal plasma.  
Repetitive UCOs in the ovine fetus leading to severe fetal acidemia did not result in overt brain 
injury or inflammation, but when additionally exposed to intraamniotic LPS, an increased in 
apoptotic cell death was observed in the hippocampus.   
This thesis provides an understanding of the fetal and placental inflammatory responses that 
occur in the near-term ovine fetus when exposed to repetitive UCOs with severe acidemia, and 
highlights the effect of underlying inflammation near the time of birth on the risk for 
subsequent brain injury.   
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